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ABSTRACT
DISTINCT TEMPORAL REQUIREMENTS FOR SONIC HEDGEHOG IN THE
DEVELOPMENT OF THE TUBERAL HYPOTHALAMUS
Tanya S. Corman
Douglas J. Epstein, Ph.D.

Sonic hedgehog (Shh) is a secreted morphogen that plays integral roles in the
development of several brain and spinal cord regions. However, defining roles for Shh in
the development of the hypothalamus has presented a challenge owing to its complex
anatomy and neuronal heterogeneity. Of particular interest is the tuberal hypothalamus,
a brain region with important homeostatic function. Early deletions of Shh from nonneuronal sources result in a severe brain malformation similar to a condition termed
Holoprosenecehpaly in humans. In mouse models of this disorder, the hypothalamus
fails to form. Later disruptions of Shh signaling within the hypothalamus itself implicate
the hypothalamic source of Shh in proper development of the optic nerve and pituitary in
addition to the hypothalamus. These phenotypes are associated with another disorder in
patients termed Septo-optic dysplasia. We use conditional deletion models in mice to
further define requirements for dynamic Shh activity at distinct stages of tuberal
hypothalamic development. We find tuberal hypothalamic nuclei are dependent on early
roles for Shh in dorsoventral patterning, neurogenesis, and restricting ventral midline
area. We then utilize fate mapping techniques to demonstrate that Shh expressing and
responsive progenitors contribute to distinct neuronal subtypes, accounting for some of
the cellular heterogeneity in tuberal hypothalamic nuclei. Conditional deletion of the
Hedgehog transducer Smoothened (Smo) at time points after dorsoventral patterning
iv

has been established reveals that Shh signaling is necessary to maintain proliferation
and progenitor identity during peak periods of hypothalamic neurogenesis. We also find
that mosaic disruption of Smo causes a non-cell autonomous gain in Shh signaling
activity in neighboring wild type cells, suggesting a possible mechanism for the growth of
hypothalamic hamartomas, a benign tumor that forms at fetal stages of hypothalamic
development.
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CHAPTER 1: INTRODUCTION
The Hypothalamus
The hypothalamus is a highly conserved brain region which acts as a critical
regulator of several homeostatic processes and animal behaviors. Neurons of the
hypothalamus are responsible for controlling diverse functions required for survival of the
organism and propagation of the species. Genetic and lesion experiments identified
neural circuits mapping to distinct areas of the hypothalamus that are responsible for
food intake, energy expenditure, fluid balance, temperature regulation, wakefulness,
daily rhythms, as well as social behaviors associated with reproduction, aggression,
arousal, and stress (Saper and Lowell, 2014; Zha and Xu, 2015; Hashikawa et al., 2017;
Tan and Knight, 2018). In order to perform this range of functions, the hypothalamus is
composed of a diverse array of neuronal cell types characterized by their expression of
transcription factors, neuropeptides, neurotransmitters, and hormones (Caqueret et al.,
2006).
An anatomically complex structure, the hypothalamus is located in the ventral
forebrain where it sits above the pituitary gland and ventral to the thalamus (Fig. 1a).
The hypothalamus is symmetrical in nature, each aspect duplicated on either side of the
ventral midline. These two halves of the hypothalamus are separated by the third
ventricle of the brain. Whereas other regions of the central nervous system are typically
arranged in cell layers, the hypothalamus is organized into discrete clusters of neurons
termed nuclei (Shimada and Nakamura, 1973; Altman and Bayer, 1986). The adult
hypothalamus is divided into four principal regions along the rostral to caudal axis:
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preoptic, anterior, tuberal, and mammillary with each region containing defined
hypothalamic nuclei (Fig. 1B).
The tuberal hypothalamus:
Perhaps the best described region of the hypothalamus is the tuberal territory.
Within the tuberal hypothalamus, beginning most ventrally, are the arcuate nucleus
(ARC), ventromedial hypothalamic nucleus (VMH), and dorsomedial hypothalamic
nucleus (DMH). The positioning of the tuberal hypothalamus offers unique exposure to
peripheral cues carried through the bloodstream or cerebrospinal fluid through a
specialized structure termed the median eminence (Yin and Gore, 2010). The median
eminence sits at the base of the third ventricle in the tuberal hypothalamus and includes
a fenestrated capillary bed, allowing for sensing of peripheral signals as well as allowing
for parvocellular neurons to release hormones to be transported to the pituitary.
Furthermore, the median eminence is derived from a specialized domain containing
networks of radial glial cells termed tanycytes (Salvatierra et al., 2014; Rizzoti and
Lovell-Badge, 2017). At the median eminence, these unique cell types are integral to the
sensing of factors including insulin, leptin, and ghrelin to allow the hypothalamus to
maintain homeostatic conditions (reviewed in Rodríguez et al., 2005; Robins et al., 2013;
reviewed in Bolborea and Dale, 2013).
The nuclei of the tuberal hypothalamus constitute the hypothalamic circuit that
regulates feeding behavior and energy homeostasis (McClellan et al., 2006; Morton et
al., 2006). Recent advances have been made in our understanding of the neuronal
circuitry and function of the VMH in particular. The VMH is an elliptical shaped nucleus
located above the ARC and below the DMH (Fig. 2) and can be subdivided into
2

ventrolateral (VMH ), central (VMH ) and dorsomedial (VMH ) regions, each with
VL

C

DM

distinguishable gene expression profiles (Segal et al., 2005; McClellan et al., 2006;
Kurrasch et al., 2007). Genetic, pharmacogenetic and optogenetic approaches have
further delineated VMH neurons into functionally distinct categories. ERα-expressing
neurons in the VMH regulate sexually dimorphic features related to energy expenditure,
VL

reproductive behavior and aggression (Lin et al., 2011; Lee et al., 2014; Correa et al.,
2015). Whereas, insulin receptor (IR) expressing neurons in the VMH and Leptin
C

Receptor (LEPR) neurons in the VMH effect body weight regulation in both males and
DM

females (Dhillon et al., 2006; Klöckener et al., 2011). Steroidogenic factor 1 (SF1,
officially designated Nr5a1) neurons in the VMH also influence behavioral responses to
DM

fear and anxiety (Silva et al., 2013; Kunwar et al., 2015).

Sonic Hedgehog

Hedgehog genes:
A major focus of developmental biology is how complex multicellular organisms
are generated from a single cell. Early experiments in the field focused on identifying
genes involved in establishing the layout or body plan of an organism. One such
discovery was that of the Hedgehog (hh) gene, identified in a mutagenesis screen in
Drosophila larvae for factors that disrupted body plan organization. Larvae mutant for hh
displayed ectopic bristle-like structures called denticles, causing them to resemble a
hedgehog (Nüsslein-Volhard and Wieschaus, 1980). In vertebrates, gene duplication
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events have expanded the Hedgehog family such that mammals have Indian hedgehog
(Ihh), Desert hedgehog (Dhh) and Sonic hedgehog (Shh).
Though there are three Hedgehog genes in mammals, Shh is perhaps the best
studied owing to its integral roles in the development of many tissues. Specifically, Shh
acts as a secreted morphogen in numerous organizing centers of the developing embryo
to pattern the limbs, central nervous system, inner ear, skin, as well as other tissues.
The best studied context is within the central nervous system, where Shh is responsible
for the patterning the neural tube along the dorsoventral axis (Echelard et al., 1993).
Hedgehog signaling pathway:
In the Shh expressing cell, Shh protein undergoes a series of post-translational
modifications and cleavage events to produce N-terminal and C-terminal fragments
(Bumcrot et al., 1995). Cholesterol molecules are then added to the N-terminal fragment
of Shh, targeting the ligand for secretion (Kelley et al., 1996; Roessler et al., 1997).
Upon release, Shh ligand travels to its cognate receptors on Shh-receiving cells. Cells
competent to receive Shh signal will express several factors required for transduction of
the signal. The ligand-binding receptor for Shh is the 12-pass transmembrane receptor
Patched (Ptch). Further, the obligate transducer of Shh signal is the G-protein-coupled
receptor-like seven-pass transmembrane protein Smoothened (Smo). In certain
contexts, additional co-receptors are also required for proper Shh signaling. These
include Cell Adhesion Associated, Oncogene Regulated (Cdon), Brother of Cdo (Boc)
and Growth arrest specific 1 (Gas1). Downstream, the Glioma-associated transcription
factors (Gli1, Gli2, and Gli3) act to activate or repress target gene transcription (Allen et
al., 2007; Goodrich et al., 1997; Van den Heuvel and Ingham, 1996; Hui et al., 1994;
4

Kinzler et al., 1988; Lee et al., 1997; Marigo et al., 1996; Tenzen et al., 2006; Zhang and
Jetten, 2001). Though the mechanisms are not fully understood, Shh requires the
primary cilium organelle for proper signaling and many components of the Shh pathway
undergo localization to the cilium as a result of Shh ligand-binding response, (Huangfu
and Anderson, 2005; Huangfu et al., 2003; Liu et al., 2005).
In the absence of ligand, Ptch1 is localized to the cilium, preventing the
accumulation of Smo in this compartment. As a result, Ptch1 acts to repress the pathway
(Rohatgi et al., 2007; Strutt et al., 2001; Taipale et al., 2002; Fig. 3.1A). Downstream,
Gli2 and 3 are bound by Suppressor of fused (Sufu). This causes the transcription
factors to remain in the cytoplasm where they are phosphorylated (Ding et al., 1999;
Kogerman et al., 1999; Liu et al., 2005; Svärd et al., 2006). These phosphorylation
events target Gli2/3 for proteolytic processing (Haycraft et al., 2005; Pan et al., 2006;
Wang et al., 2000). Cleavage of the transcriptional activator Gli2 targets it for
degradation. Meanwhile, cleavage of Gli3 releases an N-terminal repressor domain that
translocates to the nucleus and acts to repress gene expression.
Upon Shh ligand binding to Ptch1, the Ptch-mediated repression of Smo is
alleviated. Thus, Smo is able to accumulate at the tip of the primary cilium (Chen and
Struhl, 1998; Murone et al., 1999; Martín et al., 2001; Corbit et al., 2005; Rohatgi et al.,
2007). Smo accumulation at the membrane allows for downstream signaling resulting in
the dissociation of Gli proteins from Sufu. Thus, Gli2 and Gli3 are maintained in their fulllength forms and are able to translocate to the nucleus to activate transcription of target
genes, such as Gli1 (Lee et al., 1997; Wang et al., 2000; Haycraft et al., 2005; Pan et al.,
2006).
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Shh in the neural tube:
In the developing neural tube, Shh ligand is secreted first from the notochord, a
mesendodermal structure residing below the neural tube. This induces a secondary
source of Shh expression in the ventral-most cells of the neural tube termed the floor
plate. Generation of a transgenic mouse expressing a Shh-GFP fusion protein allowed
for in vivo imaging of the spread of Shh ligand from the notochord to the apical surface
of cells in the ventral neural tube (Chamberlain, 2008).
Shh ligand continues to be secreted in a graded fashion and induces the
expression of transcription factors in a concentration dependent manner. In turn, these
transcription factors pattern progenitor domains along the dorsoventral axis that will give
rise to the neuronal populations of the mature spinal cord. Downstream of ligand binding,
Shh signaling cascade results in the specification and formation of distinct domains of
progenitor cells marked by differential expression of homeodomain and basic HLH
transcription factors, activated in relation to the strength of Shh signaling to which it is
exposed (Ericson et al., 1996; Ericson et al., 1997). These transcription factors include
those termed Class I proteins, which are repressed by Shh and Class II proteins which
are induced by and require a threshold of Shh accumulation. Nkx2.2, Olig2, and Nkx6.1
characterize the three most ventral neural progenitor cell groups: p3, pMN, and p2,
respectively. Lower levels of Shh signaling also influence more dorsal p1 and p0 neural
progenitor domains (Briscoe et al., 2000; Briscoe and Ericson, 2001).
Shh in the hypothalamus:
As in the spinal cord, Shh acts to pattern ventral cell fates in the developing
hypothalamus. However, the temporal and spatial dynamics of Shh signaling in the
6

hypothalamus differ from those in more posterior regions of the CNS. Beginning at 8.5
days of mouse development (E8.5), Shh is secreted from the prechordal plate, a
mesendodermal structure that transiently underlies the anterior neural tube. This source
of Shh induces signaling activity in the overlying hypothalamus. Shh signaling is then
downregulated in ventral midline cells of the tuberal hypothalamus. This downregulation
of Shh signaling is a step which distinguishes hypothalamic development from other
regions of the central nervous system. In addition to Shh, additional factors are secreted
by prechordal plate. Interestingly, BMP ligands derived from the prechordal plate are
required for the rostralization of the neural tube to impart hypothalamic identity. (Dale et
al., 1997; Ohyama et al., 2005). This Bmp signaling in the ventral midline upregulates
Gli3-R expression, thus downregulating Shh signaling in the midline (Ohyama et al.,
2008).
Following the extinguishing of Shh signaling in the hypothalamic midline, a
secondary source of Shh transcription is induced in the hypothalamus itself between
E9.0-E9.5. At this time, Shh is initially broadly expressed in ventral hypothalamic
progenitors and then rapidly downregulated in the ventral midline at the level of the
tuberal hypothalamus (Manning et al., 2006; Trowe et al., 2013). As a result, Shh is
expressed in bilateral stripes adjacent to the ventral midline, unlike in spinal cord and
hindbrain regions where Shh is restricted to the floor plate (Echelard et al., 1993). Our
lab suggested this process is also mediated by Bmp signaling. Though the exact
mechanism is unclear, Bmp signaling induces Tbx3 expression in the ventral midline.
Tbx3 binds Sox2, interfering with the ability of Sox2 to activate the expression of Shh
(Zhao et al., 2012; Trowe et al., 2013). Moreover, neural progenitors immediately dorsal
to the bilateral stripes of Shh are responsive to Shh signaling, indicated by Gli1
7

expression, whereas progenitors located in the ventral midline remain refractory to Shh
signaling (Ohyama et al., 2008).
One additional factor which may serve to distinguish the role of Shh in patterning
of the hypothalamus from other areas of the central nervous system is Low-density
lipoprotein receptor-related protein 2 (Lrp2). Biochemical and in vivo studies of Lrp2
function have revealed Lrp2 is able to bind both Shh (as a co-receptor) and Bmp4 (as a
scavenger receptor) (McCarthy et al., 2002; Spoelgen et al., 2005; Christ et al., 2012).
Thus, Lrp2 may act to regulate a balance between Shh and Bmp signaling in the ventral
midline of the hypothalamus.

Mis-regulation of Shh in the hypothalamus:
The hypothalamus is particularly sensitive to proper levels of Shh signaling
during development. A loss of this prechordal source of Shh results in a brain
malformation termed Holoprosencephaly (HPE). As shown in Shh null mice, the
prechordal source of Shh is necessary to drive the separation of the cerebral
hemispheres, eye fields, and craniofacial structures (Chiang et al., 1996). This
prechordal source of Shh is further required for the induction of the hypothalamic
territory (Chiang et al., 1996; Dale et al., 1997). To circumvent this loss of hypothalamic
tissue, conditional approaches were used to target and identify roles for the forebrain
source of Shh. Foxb1-mediated recombination ablated Shh expression throughout the
ventral forebrain. This model left the prechordal source of Shh intact. The prechordal
plate and its source of Shh were sufficient to specify the hypothalamic territory, marked
8

by Nkx2.1, but not the identity of neuronal progenitors (Szabó et al., 2009) within the
tuberal hypothalamus.
However, in these experiments, additional forebrain sources of Shh were also
disrupted. Thus, our lab developed an SBE2-cre is a transgenic mouse line that uses
Shh brain enhancer 2 (SBE2) to activate cre transcription in the ventral diencephalon in
a similar pattern to the endogenous expression of Shh. This model allowed for the
selective deletion of Shh in the ventral diencephalon of Shh∆hyp embryos by E9.0. These
ShhΔhyp mutants display optic nerve and pituitary defects with similarities to SOD in
humans (Zhao et al., 2012). The eye and pituitary develop in close proximity to the
source of SHH in the anterior hypothalamus. However, loss-of-function mutations in
SHH have not been associated with SOD in human patients (Paulo et al., 2015; Gregory
et al., 2015). Previous work in our lab thus sought to examine whether SOD may
represent a malformation with a later manifestation compared to HPE. Specifically, HPE
and SOD may be differentiated by the timing and location of disruption in SHH signaling,
with an early loss of SHH from the prechordal plate giving rise to HPE, and a slightly
later absence of SHH from the presumptive hypothalamus resulting in SOD.
Furthermore, Shh and Gli1 continue to be expressed beyond the stage when
tuberal hypothalamic progenitors first acquire their identity and their expression extends
into the peak period of DMH, VMH and ARC neurogenesis between E12.5 and E14.5.
The experiments presented in the following chapters sought to further describe roles for
the various temporal windows of dynamic Shh expression and signaling in hypothalamic
development.

9

Chapter 1 Figures
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Figure 1. Location and organization of the hypothalamus.
(A) Schematic of the adult mouse brain highlighting the location of the hypothalamus in
blue. The four subdivisions of the hypothalamus along the rostrocaudal axis are the
preoptic area, the anterior hypothalamus, the tuberal hypothalamus, and the mammillary
hypothalamus. (B) Diagram depicting the nuclei in a cross-section through the tuberal
hypothalamus. Characteristic gene expression markers of the various nuclei are color
coded. From ventral to dorsal- the arcuate nucleus (ARC), ventrhomedial hypothalamic
nucleus (VMH) and the dorsomedial hypothalamic nucleus (DMH).

11

Figure 2. Subdivisions of the Ventromedial Hypothalamus (VMH) and associated
gene expression.
The VMH can be subdivided into dorsomedial (DM), central (C), and ventrolateral (VL)
compartments. Each compartment is associated with the expression of specific
transcription factors or receptors for neuropeptides or hormones including steroidogenic
factor-1 (SF-1), brain-derived neurotrophic factor (BDNF), estrogen receptor alpha
(ERa), leptin receptor (LepR), or insulin receptor (IR).
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CHAPTER 2: Prenatal ethanol exposure in mice phenocopies Cdon
mutation by impeding Shh function in the etiology of optic nerve
hypoplasia

Benjamin M. Kahn, Tanya S. Corman, Korah Lovelace, Mingi Hong, Robert S. Krauss,
and Douglas J. Epstein

Abstract
Septo-optic dysplasia (SOD) is a congenital disorder characterized by optic nerve,
pituitary and midline brain malformations. The clinical presentation of SOD is highly
variable with a poorly understood etiology. The majority of SOD cases are sporadic, but
in rare instances inherited mutations have been identified in a small number of
transcription factors, some of which regulate the expression of Sonic hedgehog (Shh)
during mouse forebrain development. SOD is also associated with young maternal age,
suggesting that environmental factors, including alcohol consumption at early stages of
pregnancy, might increase the risk of developing this condition. Here, we address the
hypothesis that SOD is a multifactorial disorder stemming from interactions between
mutations in Shh pathway genes and prenatal ethanol exposure. Mouse embryos with
mutations in the Shh co-receptor, Cdon, were treated in utero with ethanol or saline at
embryonic day 8 (E8.0) and evaluated for optic nerve hypoplasia (ONH), a prominent
feature of SOD. We show that both Cdon−/− mutation and prenatal ethanol exposure
independently cause ONH through a similar pathogenic mechanism that involves
selective inhibition of Shh signaling in retinal progenitor cells, resulting in their premature
13

cell-cycle arrest, precocious differentiation and failure to properly extend axons to the
optic nerve. The ONH phenotype was not exacerbated in Cdon−/− embryos treated with
ethanol, suggesting that an intact Shh signaling pathway is required for ethanol to exert
its teratogenic effects. These results support a model whereby mutations in Cdon and
prenatal ethanol exposure increase SOD risk through spatiotemporal perturbations in
Shh signaling activity.
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Introduction
Septo-optic dysplasia (SOD) is a clinically heterogeneous disorder that is
diagnosed on the presence of at least two of the following conditions: optic nerve
hypoplasia (ONH), hypopituitarism and absence of the septum pellucidum (Webb and
Dattani, 2010). The severity of these features varies widely in SOD, which has an
incidence of 1 in 10,000 live births (Patel et al., 2006). ONH is the most common finding
in SOD, and manifests as a thinning of the optic nerve as it exits the eye, resulting in
insufficient photo-transduction to the brain and, in many instances, blindness (Morishima
and Aranoff, 1986; Cemeroglu et al., 2015). Variable pituitary dysfunction, including
isolated growth hormone deficiency, central hypothyroidism, and panhypopituitarism is
also observed in individuals with SOD, with decreased levels of one or more pituitary
hormones being diagnosed by two years of age (Cemeroglu et al., 2015). Cognitive
delay and seizure disorders are also frequently seen in SOD.
The cause of SOD is poorly understood. Most cases are idiopathic, but in rare
instances (<1%) inherited mutations have been described in a small number of
transcription factors (SOX2, SOX3, HESX1, OTX2, TCF7L1) expressed during
embryonic brain development (McCabe et al., 2011; Gaston-Massuet et al., 2016). The
high phenotypic variability, coupled with its sporadic nature, suggest that SOD might be
influenced by a combination of environmental and genetic factors.
Insight into the pleiotropic nature of the SOD phenotype was recently realized
from the study of a conditional mouse mutant lacking Shh in the developing
hypothalamus (ShhΔhyp). ShhΔhyp mutants display optic nerve and pituitary defects with
similarities to SOD in humans (Zhao et al., 2012). The eye and pituitary develop in close
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proximity to the source of SHH in the anterior hypothalamus and depend on this signal
for formation of the optic disc, from where the optic nerve exits the eye, and for
coordinating pituitary morphogenesis. These findings raise the possibility that reduced
SHH expression and or signaling activity from the hypothalamus might underlie the
pathogenesis of SOD in humans. In support of this hypothesis, SOX2 and SOX3 – two
SOD-associated genes – were shown to be dose-dependent regulators of SHH
transcription that directly bind and activate a long-range SHH forebrain enhancer (Zhao
et al., 2012).
Nonetheless, loss-of-function mutations in SHH are not associated with SOD
(Paulo et al., 2015; Gregory et al., 2015), but instead are known to cause another brain
malformation, holoprosencephaly (HPE), with partially overlapping features to SOD
(Roessler et al., 1996). HPE results from imperfect separation of the cerebral
hemispheres and craniofacial structures as a result of reduction in SHH signaling from
the prechordal plate, a transient embryonic tissue required for early aspects of forebrain
development, including the specification of the hypothalamic territory (Chiang et al.,
1996). Therefore, HPE and SOD could be distinguished by the timing and location of
SHH signal disruption, with an early loss of SHH from the prechordal plate giving rise to
HPE, and a slightly later absence of SHH from the presumptive hypothalamus resulting
in SOD.
The SHH pathway has many roles during eye development. Early functions
include separation of the eye fields and patterning of the optic cup (Chiang et al., 1996).
At later stages, Shh secreted from retinal ganglion cells (RGCs) controls the proliferation
of multipotent retinal progenitor cells (RPCs), the timing of their differentiation, as well as
the guidance of RGC axons out of the eye (Wang et al., 2005; Kolpak et al., 2005;
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Sanchez-Camacho and Bovolenta, 2008; Stacher Hörndli and Chien, 2012). Mice
lacking Shh in RGCs display ONH resulting from a failure in optic disc formation
(Dakubo et al., 2003). Thus, ONH can arise by interfering with SHH signaling from two
independent sources, anterior hypothalamus and RGCs, at distinct stages of eye
development.
Epidemiological studies indicate that SOD associates with young maternal age
and primiparity (Haddad and Eugster, 2005; Murray et al., 2005; Garcia-Filion and
Borchert, 2013; Cemeroglu et al., 2015). How these risk factors contribute to the etiology
of SOD is unknown, but they might be linked to adverse maternal behavior during early
stages of pregnancy (Garcia-Filion and Borchert, 2013). For instance, several clinical
features of fetal alcohol syndrome overlap with HPE and SOD, suggesting that prenatal
ethanol exposure might increase the risk of both conditions, depending on the timing of
the insult (Sulik et al., 1981; Strömland, 1987; Coulter et al., 1993; Ashwell and Zhang,
1994; Blader and Strähle, 1998; Hellström, 1999; Ribeiro et al., 2007; Aoto et al., 2008;
Loucks and Ahlgren, 2009; Lipinski et al., 2010, 2012; Zhang et al., 2011).
The SHH signaling pathway is a key target of prenatal ethanol exposure and its
perturbation explains much of the HPE-like phenotype observed in animal models of this
condition (Ahlgren et al., 2002; Li et al., 2007; Higashiyama et al., 2007; Aoto et al.,
2008). Interestingly, mouse embryos with mutations in Shh pathway genes that have no,
or minimal, phenotypic consequence on their own, show a profound increase in the
penetrance and severity of HPE when exposed to sub-teratogenic doses of ethanol
(Hong and Krauss, 2012; Kietzman et al., 2014). The synergy between these genetic
and environmental risk factors for HPE is dependent on the timing of ethanol
administration during pregnancy, with a strong interaction observed at embryonic day 7
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(E7.0), coinciding with a disruption in Shh signaling from the prechordal plate (Hong and
Krauss, 2012).
On the basis of these studies, we postulate that SOD is a multifactorial condition
that results from interactions between genetic and environmental risk factors acting at
slightly later stages of forebrain development than those that cause HPE. To test this
hypothesis and better define the relationship between ethanol intake, Shh signaling and
SOD, we examined eye development in mouse embryos with mutations in the Shh coreceptor, Cdon, that were exposed in utero to either ethanol or saline at E8.0. Wild--type
embryos treated with ethanol phenocopied Cdon−/− mutants treated with saline in the
manifestation of ONH by selectively impeding Shh signaling activity in RPCs. The
combination of Cdon mutation and ethanol exposure did not worsen the ONH
phenotype, indicating that this gene–environment interaction is not additive or
synergistic. These results support a model whereby mutations in Cdon and prenatal
ethanol exposure are risk factors for SOD and HPE through temporally and spatially
distinct perturbations in Shh signaling activity.
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Results
We followed a previously validated protocol for prenatal ethanol exposure (see
Materials and Methods) to determine whether Cdon−/− embryos were sensitive to
ethanol-induced ONH, a prominent feature of SOD. All mice described in this study were
maintained on a 129S6/SvEvTac genetic background, which is largely impervious to the
HPE-associated phenotypes caused by Cdon mutation or ethanol exposure observed in
other mouse strains (Zhang et al., 2006; Downing et al., 2009; Hong and Krauss, 2012).
Pregnant Cdon+/− females that were time-bred with Cdon+/− males received
intraperitoneal injections of ethanol (3.48 g/kg) or saline at E8.0 and again four hours
later. This embryonic stage was chosen because it was subsequent to the HPE-critical
period at E7.0, allowing us to address the temporal specificity of gene–environment
interactions in the etiology of SOD.
Cdon mutation and prenatal ethanol exposure independently cause ONH
Cdon is expressed at early stages of eye development (E9-E11.5), including
progenitors of the neural retina and lens vesicle (Zhang et al., 2009). Cdon−/− and wildtype embryos were harvested at E14.5, cryo-sectioned along the coronal plane of their
heads, and immunostained for neurofilament. No gross abnormalities in the size or
structure of the brain were observed between wild-type and Cdon−/− embryos in either
the ethanol or saline treatment groups. Moreover, none of the prominent eye defects
displayed by Cdon−/− mutant embryos on the C57BL/6 genetic background, including
coloboma, microphthalmia and lens dysmorphology (Zhang et al., 2009) were detected
in any of the 129S6 embryos (129S6.Cdon−/−), consistent with the strain specificity of
these phenotypes.
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To assess the embryos for ONH, the diameter of the optic nerve was measured
at the level of the optic disc. Cdon−/− embryos treated with saline showed a 39%
reduction in optic nerve diameter (mean±s.d., 32.26±1.83 μm, n=9, P<0.001) compared
with control littermates (52±3.47 μm, n=8) (Fig. 3A,B,E). This difference was significant
after normalizing for eye size (Fig. 3F-H). Wild--type embryos exposed to ethanol
showed a similar reduction in optic nerve diameter (29.7±2.14 μm, n=9, P<0.001)
compared with saline-treated controls (Fig. 3A,C). This result was unexpected given that
129S6 embryos were thought to be resistant to ethanol-mediated teratogenicity
(Downing et al., 2009; Hong and Krauss, 2012), although the optic nerve was not
examined in these prior studies. The combination of Cdon mutation and prenatal ethanol
exposure did not exacerbate the ONH phenotype compared with embryos with either
condition alone. Ethanol-treated Cdon−/− embryos showed a 37% decrease in optic
nerve width (33±2.4 μm, n=8, P<0.001) compared with saline--treated controls (Fig.
3A,D), which was a similar reduction to that seen in saline-treated Cdon−/− embryos and
ethanol-treated wild-type embryos (Fig. 3A-E). These data indicate that Cdon mutation
and prenatal ethanol exposure both contribute to the etiology of ONH and that additional
risk factors, such as genetic background (129S6 versus C57BL/6) and timing of ethanol
exposure (E7.0 versus E8.0), influence the phenotypic outcome of ONH versus HPE.
Formation of the optic disc is not disturbed in Cdon−/− and ethanol-exposed
embryos
The optic nerve exits the eye through the optic disc, which forms at the juncture
of the optic stalk and cup. ONH can arise from defects in optic disc formation or from a
deficit in the number of RGC axons that make up the optic nerve (Deiner et al., 1997;
20

Dakubo et al., 2003; Zhao et al., 2012). To distinguish between these two possibilities,
we evaluated the expression of Pax2 in the optic disc of Cdon−/− and wild-type embryos
that were exposed in utero to either saline or ethanol at E8.0 of gestation. No significant
differences were observed between the number of Pax2+ cells in embryos from the
experimental and control groups (Fig. 4), thus excluding major defects in optic disc
formation as a likely explanation for the ONH phenotype in either of these mouse
models.
Shh-dependent proliferation of RPCs is compromised in Cdon−/− and ethanoltreated embryos
The absence of a synergistic interaction between Cdon−/− mutation and prenatal
ethanol exposure in the manifestation of ONH suggested that both insults might be
disrupting a common or parallel signaling pathway(s) important for eye development.
Shh is the most likely pathway to be compromised in these mouse models of ONH given
the established role of Cdon as a Shh co-receptor, the essential function of Shh in RPC
proliferation, and the negative influence of ethanol on Shh pathway activation in a variety
of developing tissues (Ahlgren et al., 2002; Wang et al., 2005; Zhang et al., 2006;
Tenzen et al., 2006; Li et al., 2007; Aoto et al., 2008; McLellan et al., 2008; Allen et al.,
2011; Hong and Krauss, 2013).
To evaluate the integrity of Shh signaling we assessed Gli1 expression, a reliable
readout of Shh pathway activation (Marigo et al., 1996), on sections through the eye at
E14.5. Wild-type embryos treated with saline showed robust expression of Gli1 in the
RPC layer of the developing eye at E14.5 (Fig. 5A). In comparison, Gli1 was markedly
reduced in the RPCs of wild-type and Cdon−/− embryos exposed to ethanol at E8.0, as
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well as Cdon−/− embryos treated with saline (Fig. 5A-D). The downregulation of Gli1
seemed to be specific to the eye as an adjacent domain of expression in the anterior
hypothalamus was unaffected across genotypes and treatment groups (Fig. 5E-H).
Moreover, Shh expression was not compromised in the eye or hypothalamus of any of
the embryos (Fig. 5I-P), suggesting that both Cdon mutation and prenatal ethanol
exposure were acting directly on some aspect of RPC development downstream of Shh.
Shh signaling maintains RPCs in a mitotically active state until they are poised to
differentiate into RGCs (Zhang and Yang, 2001; Wang et al., 2005). Therefore, we next
determined whether the downregulation in Shh signaling observed in Cdon−/− and
ethanol-treated embryos compromised the growth and differentiation properties of
RPCs. The proliferation marker Ki67 labeled 670 RPCs per section (n=3) in saline-treated wild-type embryos at E14.5 (Fig. 6A,I). By contrast, a drastic reduction in the
number of Ki67-positive RPCs was observed in Cdon−/− embryos treated with ethanol
(88 RPCs/section, n=3, P<0.001) or saline (117 RPCs/section, n=3, P<0.001), as well as
wild-type embryos exposed to ethanol (113 RPCs/section, n=3, P<0.001) (Fig. 6A-D,I).
Despite the significant reduction in Ki67 staining, trace amounts were still detected in
Cdon−/− and ethanol-treated embryos upon increased exposure times. Reduced
proliferation was also noted in the lens epithelium of Cdon−/− and ethanol-treated
embryos (Fig. 6J), as described previously (Zhang et al., 2009). The proliferation defects
seem to be specific to the eye as no significant differences were detected in the number
of Ki67-positive neural progenitors in adjacent brain regions from either genotype or
treatment group (Fig. 6E-H,K). These results suggest that the failure of RPCs to respond
to Shh signaling in both Cdon−/− and ethanol-treated embryos at E8.0 compromises their
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ability to replicate, in agreement with other studies of Shh signaling in the eye (Wang et
al., 2005).
Precocious differentiation of RGCs in Cdon−/− and ethanol-treated embryos
To determine if the differentiation of RPCs was affected by their premature cellcycle exit we assessed expression of Math5 (also known as Atoh7), a bHLH
transcription factor required at the onset of RGC differentiation (Wang et al., 2001). In
control embryos, Math5 expression was confined to postmitotic progenitors in the
ventricular zone. By contrast, in Cdon−/− and ethanol-treated embryos, Math5 expression
extended from the ventricular zone into the ganglion cell layer (Fig. 7A-D). This
observation is similar to the previous report of expanded Math5 expression in mouse
mutants that lack Shh signaling in the eye (Sakagami et al., 2009), and suggests that
loss of Shh-dependent RPC proliferation might be associated with precocious
differentiation of RPCs.
RGCs are the earliest born retinal cell type originating from a subset of RPCs
expressing Math5 (Feng et al., 2010; Brzezinski et al., 2012). The LIM homeobox
transcription factor Isl1 functions downstream of Math5, and in conjunction with the POU
domain protein Pou4F2 promotes RGC differentiation (Mu et al., 2008; Pan et al., 2008;
Prasov and Glaser, 2012; Wu et al., 2015). We evaluated the status of RGC
differentiation in Cdon−/− and ethanol-treated embryos by immunostaining for Isl1. At
E14.5, RGCs are still early in their differentiation as evidenced by the sparse labeling of
Isl1 in saline--treated wild-type embryos (225 cells/section, n=3) (Fig. 7E). However, the
number of Isl1-positive cells was increased by 32% in wild-type (329 cells/section, n=3,
P<0.05) and Cdon−/− (338 cells/section, n=3, P<0.01) embryos exposed to ethanol at
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E8.0, as well as in saline--treated Cdon−/− mutants (349 cells/section, n=3, P<0.05) (Fig.
7E-H,M). Although Isl1 is not exclusively expressed by RGCs, we did not observe
significant differences in the number of other early-born retinal progenitors, such as
amacrine cells expressing AP-2α (also known as Tfap2a), between controls and
treatment groups, suggesting that the precocious differentiation was limited to RGCs
(Fig. 7I-L,N).
These data suggest that the loss of Shh signaling in Cdon−/− and ethanol-treated
embryos results in the precocious differentiation of RGCs, which would likely deplete the
pool of non-proliferating RPCs over time (Wang et al., 2005). The significant thinning of
the optic nerve in experimental embryos likely results from the failure of these
prematurely differentiating RGCs to properly extend axons to the optic disc, a premise
that is supported by a previously characterized role for Shh in regulating the guidance of
RGC axons (Sanchez-Camacho and Bovolenta, 2008). Taken together, our results
demonstrate that prenatal ethanol exposure at E8.0 phenocopies 129S6.Cdon−/− mutant
embryos in the manifestation of ONH by selective interference with Shh-dependent
expansion and differentiation of RPCs in the eye.
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Discussion

Ethanol and Cdon mutation impede Shh signaling in RPCs to cause ONH
The association of SOD with young maternal age led to the hypothesis that
adverse behavior, including prenatal alcohol exposure, is a predisposing factor in its
etiology (Haddad and Eugster, 2005; Murray et al., 2005; Garcia-Filion and Borchert,
2013; Cemeroglu et al., 2015). Fetal exposure to alcohol causes a spectrum of
developmental disorders; however, direct evidence linking ethanol to SOD has been
lacking. Here, we used a mouse model to demonstrate that in utero exposure to ethanol
at E8.0 causes ONH, the most prevalent SOD-associated phenotype. We show that
ethanol causes ONH through a similar mechanism to that observed in Cdon−/− embryos,
involving the inhibition of Shh signaling activity in retinal progenitor cells, which leads to
their premature cell-cycle arrest, precocious differentiation, and failure to properly extend
axons to the optic nerve (Fig. 8).
These data are consistent with previous studies showing that Shh secreted from
RGCs is required to maintain RPCs in a proliferative state, thus preventing their
differentiation (Zhang and Yang, 2001; Wang et al., 2005; Sakagami et al., 2009). RGCs
also remain dependent on Shh during their maturation, as evidenced by the axonal
outgrowth defects that occur upon further inhibition of Shh (Kolpak et al., 2005;
Sanchez-Camacho and Bovolenta, 2008). Taken together, our findings implicate the
disruption of RGC-derived Shh signaling as the pathogenic mechanism by which Cdon
mutation and prenatal ethanol exposure cause ONH (Fig. 8D).
Interestingly, Cdon has also been reported to antagonize hedgehog (Hh)
signaling in the optic vesicle of zebrafish and chick embryos (Cardozo et al., 2014).
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However, we did not observe any of the gain of Hh function phenotypes described in
Cdon morphants, including expansion of Pax2-expressing cells in the ventral retina, or
increased Hh signaling in the hypothalamic territory adjacent to the eye. Moreover, the
HPE phenotype displayed by Cdon−/− mouse embryos exposed to ethanol at E7.0 was
rescued by increasing Shh signaling activity (Hong and Krauss, 2013), in contrast to the
decrease in Hh that restored eye patterning in Cdon morphants (Cardozo et al., 2014).
The differences between our findings and those of Cardozo et al. (2014) might be
related to the species in which the experiments were performed, or possibly the nature
of the genetic manipulations – germline mutation versus morpholino knockdown – that in
some cases might result in phenotypic differences resulting from distinct modes of
genetic compensation (Rossi et al., 2015).
Strain-dependent modifiers and timing of prenatal ethanol exposure influence
Shh-related phenotypes
A particularly striking feature of our mouse model is the influence that genetic
background and timing of prenatal ethanol exposure have on the variable phenotypic
severity, in keeping with other studies of ethanol-induced teratogenesis (Downing et al.,
2009; Lipinski et al., 2012). When bred on the 129S6/SvEvTac strain, both Cdon−/−
mutants and wild-type embryos exposed to ethanol at E8.0 presented with ONH. By
contrast, when raised on a C57BL/6 (C57BL/6NTac or C57BL/6J) genetic background,
both Cdon−/− embryos, and wild-type embryos exposed to ethanol one day earlier at
E7.0, exhibited HPE (Zhang et al., 2006; Higashiyama et al., 2007; Aoto et al., 2008;
Godin et al., 2010). Thus, strain-dependent modifiers of the Cdon−/− mutation and timing
of prenatal ethanol exposure affect the spatiotemporal dynamics of Shh pathway
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disruption in the eye and prechordal plate, which influences the likelihood of developing
ONH versus HPE, respectively.
It is intriguing that we did not detect any interaction between Cdon−/− mutation
and ethanol in the manifestation of ONH, or other SOD-related phenotypes, whereas
synergy between the two insults was observed for HPE (Hong and Krauss, 2012). This
finding suggests that the eye is especially vulnerable to genetic and environmental
perturbations in Shh signaling, at least on the more resistant 129S6 background.
Pituitary hypoplasia is another prominent feature of SOD that arises from Shh pathway
disruption (Treier et al., 2001; Wang et al., 2010; Zhao et al., 2012). However, Shh
expression in the anterior hypothalamus, which is required for pituitary morphogenesis,
was not affected in the embryos analyzed in our study. Hence, more impactful
perturbations in Shh signaling might be needed to compromise pituitary development, as
described in other mouse models of SOD (Zhao et al., 2012; Gaston-Massuet et al.,
2016).
Effects of ethanol on Shh signaling
Another interpretation for the inability of ethanol to worsen the ONH phenotype in
Cdon−/− mutants is that an intact Shh signaling pathway is required for ethanol to exert
its teratogenic effect. Ethanol treatment reduces Shh signaling through diverse
mechanisms, including the activation of Shh pathway antagonists (PKA), repression of
Shh pathway modulators (cholesterol), and indirect consequences that decrease the
survival of Shh-expressing and/or responsive cells, possibly owing to increased oxidative
stress (Ahlgren et al., 2002; Li et al., 2007; Aoto et al., 2008; Zhang et al., 2011). In each
of these examples the acute effect of ethanol on Shh signaling is short-lived, occurring
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close to the developmental stage when Shh function is required. However, in our study
Shh is not expressed in the eye until several days after ethanol administration,
suggesting that ethanol-induced alterations persist beyond the time of exposure.
One potential mechanism by which ethanol might invoke long-lasting changes in
gene expression is through epigenetic modifications of DNA and chromatin structure
(Kleiber et al., 2014). Acetyl-CoA is an end product of ethanol metabolism and, among
its many cellular functions, serves as a substrate for histone acetylation. Stable
alterations in the acetylation and methylation of histone tails at several loci were
detected in the cerebral cortex of E17 mouse embryos after in utero ethanol exposure at
E7.0 (Veazey et al., 2015). Whether these ethanol-induced changes in histone
modifications alter gene expression programs that are responsible for specific
developmental defects requires further experimentation. Nonetheless, these
observations suggest an intriguing model in which prenatal ethanol exposure at E8.0
perturbs the epigenetic landscape leading to alterations in Shh-dependent gene
expression in the eye at E14.5 (Fig. 8C).
SOD is a multifactorial disorder
The idiopathic nature of most SOD cases suggests a multifactorial etiology to this
debilitating condition, including sporadic mutations and environmental teratogens that
impinge on Shh-dependent mechanisms of eye and pituitary development. Exome and
whole-genome sequencing of SOD cases should assist in the identification of as-yet
undiscovered genetic variants that increase disease risk. Although our study
demonstrated the adverse effects of prenatal ethanol exposure on Shh signaling during
eye development, other drugs, including cannabinoids and their more potent synthetic
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derivatives, might also contribute to disease pathogenesis by interfering with Shh signal
transduction at key stages of embryonic development (Khaliullina et al., 2015; Gilbert et
al., 2015). The use of drugs and alcohol at early stages of pregnancy is particularly
harmful to the embryo because it coincides with a sensitive period of brain development
during the first month when young mothers are often unaware of their pregnancy. A
better understanding of the gene–environment interactions underlying SOD risk might
improve treatment options, time to diagnosis, and public awareness of the importance
for early prenatal care, even when pregnancy is inadvertent.
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Materials and Methods
Mice
All animal work was approved by the Institutional Animal Care and Use Committee
(IACUC) at the Icahn School of Medicine at Mount Sinai and the Perelman School of
Medicine, University of Pennsylvania. The animal facilities at both institutions are
accredited by the Association for Assessment and Accreditation of Laboratory Animal
Care International (AAALAC). Detailed methods for all mouse breeding experiments, in
utero ethanol administration, measurements of maternal blood alcohol concentration and
embryo harvest are described in Hong and Krauss (2012). Briefly, Cdon+/− mice on a
129S6/SvEvTac (129S6) background were mated for one hour in the dark and checked
for the presence of a vaginal plug. The time of plug detection was designated as
embryonic day 0 (E0). Pregnant female mice were injected intraperitoneally with 15 μl/g
body weight of a solution of 30% ethanol in saline (3.48 g/kg) at E8.0, and again 4 h
later. Saline injections were used as a control. Generation of mice with a targeted Cdon
null allele was described previously (Cole and Krauss, 2003).

Immunohistochemistry and in situ hybridization
Embryos were harvested at E14.5, fixed overnight in 4% paraformaldehyde at 4°C,
washed in PBS, dehydrated through a graded ethanol series, and stored in 100%
ethanol at −20°C. Embryos were rehydrated in PBS, cryoprotected in 30% sucrose
overnight at 4°C, embedded in Tissue-Tek OCT Compound (Sakura Finetek USA, Inc.,
Torrance, CA), quick-frozen on dry ice, and cryosectioned at 16 µm. Primary antibodies
used for immunohistochemistry and their dilutions are as follows: mouse anti30

neurofilament (1:250, 2H3), mouse anti-islet1/2 (1:100, 39.4D5), mouse anti AP-2alpha
(1:100, 5E4) were obtained from Developmental Studies Hybridoma Bank (University of
Iowa, Iowa City, IA); rabbit anti-Pax2 (1:250, 71-6000, Invitrogen); mouse anti-Ki67
(1:1000, ACK02, Leica Biosystems). Detection of primary antibodies was achieved using
secondary antibodies conjugated to Cy3 (1:100, 115-106-006, Jackson
ImmunoResearch Laboratories) or Alexa 488 (1:100, A32723, Molecular Probes).
Section in situ hybridization was performed with digoxygenin-UTP-labeled riboprobes
essentially as described (Nissim et al., 2007). At least three to five embryos in the
experimental and control groups were evaluated for each antibody or in situ probe.

Quantification and statistical analysis
All cell counts were performed using the cell counter function in ImageJ (NIH) on tissue
sections from at least three embryos of each experimental and control group. The width
of the optic nerve was determined at its mid-point using image software in the Leica
Application Suite (Leica Microsystems). The axial width and length of each eye was also
determined. Eye measurements were taken from at least eight embryos of each
experimental and control group that were blind to the observer. Statistical analysis was
performed in GraphPad Prism using the Student's t-test.
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Chapter 2 Figures

Figure 3. Cdon mutation and ethanol exposure independently cause optic nerve
hypoplasia.
(A-D) Immunostaining for neurofilament (green) on transverse sections through the eye
at E14.5 labels the optic nerve (arrow). Compared with (A) saline-treated wild-type
(Cdon+/+) embryos (n=9), the diameter of the optic nerve (white line) is significantly
reduced in (B) saline-treated Cdon−/− mutants (n=8), (C) ethanol-treated wild-type
embryos (n=9), and (D) ethanol-treated Cdon−/− mutants (n=9). Scale bar: 200 µm. (EH) Quantification of (E) optic nerve diameter, (F) axial length of eye, (G) axial width of
eye, and (H) optic nerve diameter (OND) normalized to axial width (AW) of the eye. Error
bars represent s.d. **P<0.01, ***P<0.001 by Student's t-test
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Figure 4. The optic disc is not compromised in Cdon−/− or ethanol-treated
embryos.
(A-D) Immunostaining for Pax2 on transverse sections through the eye at E14.5 marks
the optic disc (arrows). No significant differences were observed in the average number
of Pax2+ optic disc cells per section from (A) saline-treated wild-type (Cdon+/+) embryos
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(n=6), (B) saline-treated Cdon−/− mutants (n=8), (C) ethanol-treated wild-type embryos
(n=8), and (D) ethanol-treated Cdon−/− mutants (n=8). Scale bar: 200 µm. (E)
Quantification of Pax2+ optic disc cells. Error bars represent s.d. Student's t-test.
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Figure 5. Selective reduction of Gli1 expression in the eyes of Cdon−/− and ethanoltreated embryos.
In situ hybridization for Gli1 (A-H), and Shh (I-P) on transverse sections through the eye
(A-D,I-L) and hypothalamus (E-H,M-P) of E14.5 wild-type (Cdon+/+) and Cdon−/− embryos
treated with saline or ethanol at E8.0. Gli1 expression is detected in retinal progenitor
cells (RPCs, area marked by dotted white line) of (A) saline-treated wild-type embryos
(n=5). Gli1 expression is markedly reduced in RPCs of (B) saline-treated Cdon−/−
mutants (n=5), (C) ethanol-treated wild-type embryos (n=9), and (D) ethanol-treated
Cdon−/− mutants (n=5). No differences were observed in the expression of Gli1 in the
hypothalamus between genotypes or treatment groups (E-H). No differences were
observed in the level of Shh expression in retinal ganglion cells (RGCs, area marked by
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dotted black line, I-L) or the hypothalamus (M-P) between genotypes or treatment
groups. Scale bar: 200 µm.
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Figure 6. Reduced proliferation of RPCs in Cdon−/− and ethanol-treated embryos.
(A-H) Immunostaining for Ki67 on transverse sections through the eye (A-D) and
hypothalamus (E-H) of E14.5 embryos labels proliferating progenitors. (A) The majority
of retinal progenitor cells (RPCs, area marked by dotted white line) in saline-treated wildtype (Cdon+/+) embryos (n=3), are marked by Ki67. The number of Ki67+ RPCs is
significantly reduced in (B) saline-treated Cdon−/− embryos (n=3), (C) ethanol-treated
wild-type embryos (n=3), and (D) ethanol-treated Cdon−/− embryos (n=3). No differences
in the number of Ki67+ cells in the ventricular layer of the ventral hypothalamus (boxed
area) were observed between genotypes or treatment groups (E-H). Scale bar: 200 µm.
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(I-K) Quantification of Ki67+ cells in (I) retina, (J) lens and (K) hypothalamus sections
across all experimental groups. Error bars represent s.d. *P<0.05, **P<0.01, ***P<0.001
by Student's t-test.
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Figure 7. Precocious differentiation of RGCs in Cdon−/− and ethanol-treated
embryos.
(A-D) In situ hybridization for Math5 on transverse sections through the eye at E14.5
labels postmitotic progenitors in the ventricular zone (vz) of control embryos (n=3) (A).
Math5 expression expands into the ganglion cell layer (gcl) of Cdon−/− and ethanoltreated embryos (n=3 for each experimental group) (B-D). Dashed line marks the vz–gcl
boundary. (E-H) Immunostaining for Isl1/2 on transverse sections through the eye of
E14.5 embryos primarily labels differentiating retinal ganglion cells (RGCs, arrows).
Compared with (E) saline-treated wild-type (Cdon+/+) embryos (n=3), the number of
Isl1/2+ RGCs is significantly increased in (F) saline-treated Cdon−/− mutants (n=3), (G)
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ethanol-treated wild-type embryos (n=3), and (H) ethanol-treated Cdon−/− mutants (n=3).
(I-L) Immunostaining for AP-2α in amacrine cells. No significant differences were
observed between the average number of AP-2α+ amacrine cells per section from (I)
saline-treated wild-type (Cdon+/+) embryos (n=4), (J) saline-treated Cdon−/− mutants
(n=3), (K) ethanol-treated wild-type embryos (n=4), and (L) ethanol-treated Cdon−/−
mutants (n=3). Scale bar: 50 µm. (M,N) Quantification of cells expressing Isl1/2 (M) and
AP-2α (N). Error bars represent s.d. *P<0.05, **P<0.01 by Student's t-test.
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Figure 8. Model depicting the influence of Cdon mutation and ethanol exposure on
Shh signaling activity in the developing eye.
(A) In wild-type embryos (E14.5), the binding of Shh to Cdon and Ptch1 releases the
inhibition on smoothened (Smo), facilitating the transcription by Gli activator (GliA) of
target genes involved in RPC proliferation. (B) In the eyes of 129S6.Cdon−/− embryos,
there is persistent inhibition of Smo by Ptch1, even in the presence of Shh, causing Gli
repressor (GliR) to block transcription of genes involved in RPC proliferation, resulting in
precocious RPC differentiation. (C) Ethanol exposure at E8.0 interferes with Shh
signaling in the eye through a variety of proposed mechanisms. The lengthy delay
between ethanol exposure (E8.0) and its negative effects on Shh signaling activity
(E14.5), suggests that the epigenetic landscape of Shh target genes might be modified
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to suppress RPC proliferation. (D) Cdon mutation or ethanol exposure at E8.0 impedes
Shh signaling activity in RPCs resulting in optic nerve hypoplasia.
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CHAPTER 3: Distinct temporal requirements for Sonic hedgehog signaling
development of the tuberal hypothalamus

Tanya S. Corman, Solsire Zevallos, and Douglas J. Epstein

Note: The work in this chapter was submitted to Development on May 7, 2018. Reviewer
comments were received on May 29, 2018. Revisions are ongoing.

Abstract
Roles for the secreted morphogen, Sonic hedgehog (Shh), have been well characterized
in several brain and spinal cord regions. However, the hypothalamus has presented a
particular challenge owing to its complex anatomy and neuronal heterogeneity. Here, we
utilize fate-mapping and conditional deletion models in mice to define requirements for
dynamic Shh activity at distinct stages of tuberal hypothalamic development, a brain
region with important homeostatic functions. Tuberal hypothalamic nuclei are dependent
on early roles for Shh in dorsoventral patterning, neurogenesis and restricting ventral
midline area. Fate mapping experiments demonstrate that Shh expressing and
responsive progenitors contribute to distinct neuronal subtypes, accounting for some of
the cellular heterogeneity in tuberal hypothalamic nuclei. Conditional deletion of the
Hedgehog transducer Smoothened (Smo), after dorsoventral patterning has been
established, reveals that Shh signaling is necessary to maintain proliferation and
progenitor identity during peak periods of hypothalamic neurogenesis. We also find that
mosaic disruption of Smo causes a non-cell autonomous gain in Shh signaling activity in
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neighboring wild type cells, suggesting a possible mechanism for the growth of
hypothalamic hamartomas, a benign tumor that forms at fetal stages of hypothalamic
development.
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Introduction
The hypothalamus is an ancient brain region with important roles in the
regulation of several homeostatic processes and animal behaviors. Neural circuits
mapping to distinct areas of the hypothalamus control a variety of essential bodily
functions, including food intake, energy expenditure, fluid balance, temperature
regulation, wakefulness, daily rhythms, as well as social behaviors associated with
reproduction, aggression, arousal, and stress (Saper and Lowell, 2014; Zha and Xu,
2015; Hashikawa et al., 2017; Tan and Knight, 2018). Organized into small clusters of
neurons, termed nuclei, the hypothalamus is unlike other regions of the central nervous
system (CNS) that are typically arranged in cell layers (Shimada and Nakamura, 1973;
Altman and Bayer, 1986). Further adding to this complex architecture, most
hypothalamic nuclei are composed of diverse neuronal cell types with opposing or
sometimes unrelated functions. The developmental mechanisms regulating neuronal
heterogeneity within hypothalamic nuclei are poorly understood compared to other CNS
regions (Bedont et al., 2015; Burbridge et al., 2016; Xie and Dorsky, 2017).
The hypothalamus derives from the ventral diencephalon and can be divided into
four principal regions from rostral to caudal: preoptic, anterior, tuberal, and mammillary.
Within the tuberal hypothalamus, neurons in the arcuate nucleus (ARC), ventromedial
hypothalamic nucleus (VMH), dorsomedial hypothalamic nucleus (DMH), and
paraventricular nucleus (PVN) integrate sensory information from the environment in
order to illicit autonomic, endocrine and behavioral responses that maintain vital set
points in the animal or adapt to various stressors (Saper and Lowell, 2014). In addition to
receiving inputs from other brain regions, the positioning of the tuberal hypothalamus
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offers unique exposure to peripheral cues carried through the bloodstream which are
presented to neurons at the median eminence.
Recent advances have been made in our understanding of the neuronal circuitry
and function of tuberal hypothalamic nuclei. This is particularly true for the VMH, an
elliptical shaped nucleus located above the ARC and below the DMH (Fig. 9). The VMH
is subdivided into ventrolateral (VMHVL), central (VMHC) and dorsomedial (VMHDM)
regions, each with distinguishable gene expression profiles (Segal et al., 2005;
McClellan et al., 2006; Kurrasch et al., 2007). Genetic, pharmacogenetic and
optogenetic approaches have further delineated VMH neurons into functionally distinct
categories. ERα-expressing neurons in the VMHVL regulate sexually dimorphic features
related to energy expenditure, reproductive behavior and aggression (Lin et al., 2011;
Lee et al., 2014; Correa et al., 2015). Whereas, insulin receptor (IR) expressing neurons
in the VMHC and Leptin Receptor (LEPR) neurons in the VMHDM effect body weight
regulation in both males and females (Dhillon et al., 2006; Klöckener et al., 2011).
Steroidogenic factor 1 (SF1, officially designated Nr5a1) neurons in the VMHDM also
influence behavioral responses to fear and anxiety (Silva et al., 2013; Kunwar et al.,
2015).
Despite the progress in assigning function to VMH neurons, we still know
relatively little about how this nucleus forms and the process by which its subdivisions
are established. During hypothalamic development, Nr5a1 is selectively expressed by all
VMH neurons soon after they exit the cell cycle and undergo neurogenesis (Tran et al.,
2003). Nr5a1 is required for the terminal differentiation of VMH neurons, as well as their
coalescence into a nucleus with a distinct cytoarchitecture (Ikeda et al., 1995; Davis et
al., 2004; Büdefeld et al., 2011). Consequently, mice lacking Nr5a1 in the VMH are
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obese, anxious, and infertile (Majdic et al., 2002; Zhao et al., 2008; Kim et al., 2010).
Additional cell type specific factors acting upstream of Nr5a1 remain to be identified.
One signaling molecule that may help bridge the gap in knowledge concerning
the ontogeny of VMH neurons is Sonic Hedgehog (Shh). Shh has been studied in
several spatial and temporal contexts related to hypothalamic development. Shh
signaling from the prechordal plate, which underlies the ventral forebrain at early stages
of its development, is required for the induction of the hypothalamic territory (Chiang et
al., 1996; Dale et al., 1997). The conditional deletion of Shh in the ventral diencephalon
causes defects in the patterning, regionalization and formation of ventral hypothalamic
nuclei (Szabó et al., 2009; Shimogori et al., 2010; Zhao et al., 2012; Carreno et al.,
2017). Nevertheless, the pathogenic mechanisms underlying these Shh dependent
alterations in hypothalamic development have yet to be fully realized. Moreover, since
Shh continues to be expressed in VMH progenitors well beyond the initial patterning
stage, additional roles for Shh in VMH nucleogenesis and neuronal subtype identity are
likely (Alvarez-Bolado et al., 2012).
Here, we use conditional knockout mice to interrogate the functional
requirements of Shh signaling at specific periods of hypothalamic development. We
show that the pronounced loss of hypothalamic nuclei that manifests from the early
deletion of Shh at embryonic day 9 (E9.0) is caused by defects in dorsoventral
patterning, neurogenesis and the expansion of ventral midline cells, indicating a novel
role for Shh in restricting ventral midline development in the tuberal hypothalamus. Fate
mapping experiments reveal that Shh expressing and Shh responsive cell lineages are
enriched in distinct domains of the VMH, contributing to the neuronal heterogeneity of
this nucleus. The deletion of Smoothened (Smo), an essential transducer of Shh
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signaling, at later stages of hypothalamic development (after E10.5), results in a cell
autonomous loss of VMH neuronal subtype identity. Remarkably, we also detect a noncell autonomous expansion and reprogramming of neighboring wild type cells, which
likely occurs in response to residual Shh ligand that was not taken up by Smo mutant
cells. This gain in Shh signaling activity may explain the pathogenesis of hypothalamic
hamartomas (HH), a benign tumor caused, in some cases, by somatic gene mutations
that block Shh responsiveness (Saitsu et al. 2016; Hildebrand et al., 2016).

48

Results

Shh is required for the development of tuberal hypothalamic nuclei
To determine how Shh signaling contributes to the formation of tuberal
hypothalamic nuclei we first evaluated the expression of cell type specific markers in
SBE2-cre; Shhloxp/- (Shh∆hyp) embryos. SBE2-cre is a transgenic mouse line that uses
Shh brain enhancer 2 (SBE2) to activate cre transcription in the ventral diencephalon in
a similar pattern to the endogenous expression of Shh. We previously showed that Shh
is selectively deleted in the ventral diencephalon of Shh∆hyp embryos by E9.0 (Zhao et
al., 2012). The expression of cell type specific markers of the DMH (Hmx3), VMH
(Nr5a1) and ARC (Pro-opiomelanocortin, POMC; Tyrosine Hydoxylase, TH; and
Somatostatin, Sst) nuclei was either absent or greatly diminished in Shh∆hyp embryos at
E14.5 (Fig. 9A-K; POMC: control 140.8 ± 52.9, Shh∆hyp 1.0 ± 1.7, n=5, p=0.0004; TH:
control 104.0 ± 13.2, Shh∆hyp 12.3 ± 6.6, n=4, p<0.0001; Sst: control 63.0 ± 3.0, Shh∆hyp
0.3 ± 0.6, n=3, p<0.0001). Ectopic expression of Hmx3 was also detected in the VMH,
possibly due to its derepression in the absence of Shh (Fig. 9A, B). These results are
consistent with previous findings demonstrating a requirement for Shh in the
development of tuberal hypothalamic nuclei (Fig. 9L-N; Szabó et al., 2009; Shimogori et
al., 2010; Carreno et al., 2017).
Alterations in dorsoventral patterning, neurogenesis and ventral midline formation
explain the absence of tuberal hypothalamic nuclei in Shh ∆hyp embryos
Shh signaling is required to establish distinct neuronal identities at ventral
positions along the length of the vertebrate neural tube through the activation and
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repression of homeodomain and basic helix-loop-helix (bHLH) transcription factors
(Ericson et al., 1997; Briscoe et al., 1999; Briscoe et al., 2000; Muhr et al., 2001;
Balaskas et al., 2012). However, the temporal and spatial dynamics of Shh signaling in
the hypothalamus differ from more posterior regions of the CNS. Shh is initially broadly
expressed in ventral hypothalamic progenitors and then rapidly downregulated in the
ventral midline at the level of the tuberal hypothalamus (Manning et al., 2006; Trowe et
al., 2013). Consequently, Shh is expressed in bilateral stripes adjacent to the ventral
midline, unlike spinal cord and hindbrain regions where Shh is restricted to the floor plate
(Fig. 10A; and Echelard et al., 1993). Moreover, neural progenitors immediately dorsal to
the bilateral stripes of Shh are responsive to Shh signaling, indicated by Gli1 expression,
whereas progenitors located in the ventral midline are refractory to Shh signaling (Fig.
10B; and Ohyama et al., 2008).
We evaluated key patterning genes in Shh∆hyp mutants at E10.5 to address
whether alterations in their expression might explain the loss of tuberal hypothalamic
nuclei at later stages. As expected, Shh and Gli1 were absent in Shh∆hyp embryos (Fig.
10A,B,H,I). The number of cells expressing Nkx2.1, a broad determinant of ventral
hypothalamic progenitor identity (Kimura et al., 1996; Sussel et al., 1999), was reduced
by 48% in Shh∆hyp embryos compared to control littermates (Fig. 10C,J,O; control: 540.8
± 56.4, n=5; Shh∆hyp: 282.0 ± 22.0, n=6, p<0.0001). In addition, Pax6, a prethalamic
marker was expanded ventrally to a position abutting the Nkx2.1 domain (Fig. 10C,J).
Nkx2.2 is expressed in Shh responsive progenitors of the DMH that occupy the gap
between Pax6 and Nkx2.1 (Fig. 10D). The expression of Nkx2.2 was dramatically
reduced in Shh∆hyp embryos (Fig. 10D,K,P; control: 221.0 ± 21.2, n=4; Shh∆hyp: 1.6 ± 2.1,
n=5, p<0.0001), which may explain the ventral expansion of Pax6 due to deficient cross50

repressive interactions between these transcription factors (Ericson et al., 1997; Briscoe
et al., 1999; Muhr et al., 2001). These results suggest that alterations in the dorsoventral
patterning of tuberal hypothalamic progenitors are responsible, at least in part, for the
loss of their identities in Shh∆hyp embryos.
The bHLH transcription factor, Ascl1, is required for ARC and VMH neurogenesis
(McNay et al., 2006). We observed an 81% reduction in the number of Ascl1 expressing
cells in the ventral hypothalamus of Shh∆hyp embryos compared to control littermates
(Fig. 10E,L,Q; control: 252.7 ± 11.7, n=3; Shh∆hyp: 47.0 ± 18.5, n=3, p<0.0001).
Therefore, the reduction of neuroendocrine neurons in the ARC and VMH nuclei of
Shh∆hyp embryos may also be explained by the downregulation of Ascl1.
Another striking feature of Shh∆hyp embryos is the dysmorphic appearance of the
ventral midline. Rather than the V-shaped morphology typical of wild type embryos, the
ventral midline of Shh∆hyp embryos is U-shaped with a flattened appearance (Fig.
10F,M). Ventral midline cells in the tuberal hypothalamus undergo BMP dependent cellcycle arrest and express the T-box protein, Tbx3 (Manning et al., 2006; Trowe et al.,
2013). We quantified the zone of non-proliferation by counting the number of DAPI
positive nuclei in the Ki67 negative ventral midline territory and observed a significant
increase in Shh∆hyp embryos (Fig. 10F,M,R; 50.5 ± 3.7, n=4) compared to control
littermates (14.67 ± 1.5, n=3, p<0.0001). The length of the ventral midline territory
marked by Tbx3 was also significantly increased in Shh∆hyp embryos (Fig. 10G,N,S;
239.1 ± 8.2 µm, n=3) compared to control littermates (96.7 ± 11.6 µm, n=3, p=0.0001).
These results demonstrate that the loss of Shh in the tuberal hypothalamus expands the
fate of non-dividing ventral midline cells at the expense of proliferating Nkx2.1 positive
neural progenitors. Interestingly, Bmp4 was previously shown to be upregulated in the
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ventral midline of Shh∆hyp embryos (Zhao et al., 2012). Hence, our findings highlight a
unique role for Shh in restricting the size of the ventral midline in the tuberal
hypothalamus by opposing Bmp signaling, in stark contrast to the floor plate promoting
activity of Shh in more posterior regions of the CNS (Echelard et al., 1993; Roelink et al.,
1994; Roelink et al., 1995; Marti et al., 1995; Ericson et al., 1996; Chiang et al., 1996).
Descendants of Shh expressing progenitors contribute to the VMH
Shh and Gli1 continue to be expressed beyond the stage when tuberal
hypothalamic progenitors first acquire their identity and extend into the peak period of
DMH, VMH and ARC neurogenesis between E12.5 and E14.5 (Fig. 11). We next sought
to determine the relative contributions of Shh expressing and Shh responsive
progenitors to distinct tuberal hypothalamic nuclei. We used a genetic fate mapping
strategy to indelibly label Shh expressing (ShhCreER) and Shh responsive (Gli1CreER)
progenitors with an inducible GFP reporter (RosaZsGreen). Pregnant dams carrying either
ShhCreER/+; RosaZsGreen/+ or Gli1CreER/+; RosaZsGreen/+ embryos were administered tamoxifen
at E10.5. The contribution of Shh and Gli1 expressing cells to tuberal hypothalamic
nuclei was evaluated by co-labeling with GFP and cell type specific markers at E14.5.
The majority of postmitotic neurons in the VMH express Nr5a1 and Nkx2.1 at
E14.5 (Fig. 12A,B; Correa et al., 2015). GFP+ cells in ShhCreER/+; RosaZsGreen/+ embryos
were detected in the ventricular zone adjacent to the VMH as well as 46% of Nr5a1
positive neurons (Fig. 12A,G). This finding suggests that Shh expressing progenitors in
the ventricular zone of the tuberal hypothalamus migrate radially to populate the VMH, in
agreement with a previous study (Alvarez-Bolado et al., 2012). GFP and Nr5a1 double
labeled neurons were enriched in ventral (199.3 ± 11.9, n=3) compared to dorsal (112.3
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± 8.0, n=3, p=0.0005) regions of the VMH in ShhCreER/+; RosaZsGreen/+ embryos (Figs. 12A
and 13). A similar ventral VMH bias was observed for GFP and Nkx2.1 double labeled
neurons (Fig. 12B). Nkx2.2 is expressed in a subset of post-mitotic neurons in the dorsal
VMH, of which 22% co-label with GFP (Fig. 12C,G). These data reveal that descendants
of Shh expressing progenitors marked with GFP at E10.5 are partitioned along the
dorsoventral axis of the VMH into primarily ventral and central positions and are largely
excluded from the dorsal most region (Figs. 12J and 13).
We also assessed the contribution of Shh expressing progenitors to other tuberal
hypothalamic nuclei. The DMH is composed of GABA-ergic neurons that express Gad1
and a subset of neurons that express Isl1. No overlap in GFP and Gad1 or Isl1 was
observed in the DMH of ShhCreER/+; RosaZsGreen/+ embryos, suggesting that Shh
expressing progenitors do not contribute to this nucleus when labeled at E10.5 (Fig.
12H-J). Some overlap between GFP and Isl1 was observed in ventrolateral neurons in
the VMH, as well as a small subset of ARC neurons (Fig. 12I,N). In summary, Shh
expressing neuronal progenitors in the tuberal hypothalamus predominantly contribute to
the VMH when labeled at E10.5.
Descendants of Gli1 expressing progenitors contribute to the DMH and VMH
We next examined the fate of Shh responsive cells in Gli1CreER/+;
RosaZsGreen/+embryos administered tamoxifen at E10.5 and collected at E14.5. Given that
Gli1 is expressed dorsal to Shh, we expected that GFP+ cells would be confined to the
DMH. Indeed, GFP+ cells were detected in the ventricular zone immediately adjacent to
the DMH, as well as in Gad1 and Isl1 expressing neurons that appeared to migrate
radially into the DMH (Fig. 12K-N).
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Surprisingly, we also identified a small population of Nr5a1 neurons in the VMH
of Gli1CreER/+; RosaZsGreen/+ embryos that co-labeled with GFP (Fig. 12D,G; 10.6% ± 1.4%,
n=3). These GFP+ cells appeared to stream ventrally from a more dorsal progenitor
domain to occupy a dorsolateral region of the VMH (Fig. 12D-F). GFP and Nr5a1 double
labeled neurons were enriched in dorsal (57.3 ± 13.5, n=3) compared to ventral (5.0 ±
1.7, n=3, p=0.002) regions of the VMH in Gli1CreER/+; RosaZsGreen/+ embryos (Figs. 12D
and 13). GFP co-labeling was also observed with Nkx2.1 and Nkx2.2 in primarily dorsal
regions of the VMH (Fig. 12E-G). These data suggest that VMH neurons originate from
spatially segregated pools of Shh expressing and Shh responsive progenitors that may
contribute to the cellular heterogeneity of the VMH (Fig. 12J,M).
Shh signaling is required to maintain tuberal hypothalamic progenitors in a
proliferative state
The results of our lineage tracing and gene expression experiments
demonstrated that Shh signaling is active in tuberal hypothalamic progenitors after their
dorsoventral identity is established. To address whether Shh signaling is also required at
later stages of DMH and VMH neurogenesis we generated mice in which Smoothened
(Smo), an essential regulator of Shh signaling, was conditionally deleted in Gli1
expressing cells after E10.5.
Pregnant dams carrying Gli1CreER/+; Smoloxp/-; RosaZsGreen/+ (cSmo) and Gli1CreER/+;
Smoloxp/+; RosaZsGreen/+ (control) embryos were administered tamoxifen at E10.5 and
collected at different developmental stages. Strikingly, the number of GFP positive cells
in the tuberal hypothalamus was decreased by 43% in cSmo embryos (453.8 ± 52.27,
n=8) compared to control littermates (800.2 ± 155.3, n=9, p=0.0003) when harvested at
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E14.5 (Fig. 14A-C). This reduction in GFP+ cells was detected in both mantle and
ventricular zones. A significant reduction in the number of GFP+ cells was also observed
one day earlier at E13.5 (Fig. 14D-F; cSmo: 418.1 ± 45.5, n=7, versus control: 603 ±
138.9, n=6, p=0.0066), but not at E12.5 (Fig.14 G-I; cSmo: 512.4 ± 96.1, n=5, versus
control: 578.6 ± 96.7, n=5, p>0.05).
The failed expansion of Shh responsive cells in cSmo embryos between E12.5
and E14.5 might be explained by increased cell death, decreased proliferation, or both.
Immunostaining for activated caspase-3, an indicator of apoptosis, was minimal in cSmo
and control embryos at E14.5 with no significant differences between genotypes (Fig.
15). On the other hand, fewer GFP positive cells co-labeled with the proliferation marker
Ki67 in the ventricular zone of cSmo embryos at E12.5 (Fig. 14J-L; 28.5% ± 6.2%, n=3)
compared to control littermates (50.1% ± 8.7%, n=9, p=0.0249). From these results, we
conclude that Shh signaling is required to maintain tuberal hypothalamic progenitors in a
mitotically active state during the peak period of VMH and DMH neurogenesis.
Cell-autonomous requirement for Smo in promoting tuberal hypothalamic neuron
identity
Given the contribution of Shh responsive cells to distinct neuronal subtypes in the
DMH and VMH, we next assessed whether aspects of their identity were compromised
in cSmo mutants. We observed a 30% reduction in the number of Isl1 positive neurons
in the DMH of cSmo (Fig. 16A-C; 477.6 ± 130.7, n=5) compared to control littermates
(678.3 ± 44.6, n=4, p=0.0229). There was also a 30% reduction in the number of
neurons expressing Nkx2.2 in the dorsal VMH of cSmo (Fig. 16D-F; 315.2 ± 52.1, n=9)
compared to control embryos (451.6 ± 28.2, n=9; p<0.0001). These findings, in
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conjunction with the proliferation defects described above, suggest that the conditional
loss of Shh signaling after E10.5 causes a cell autonomous reduction of distinct DMH
and VMH neuronal subtypes.

Non-cell autonomous defects in cSmo embryos alter VMH neuron subtype identity
Remarkably, despite the reduction of Nkx2.2 staining in cSmo embryos, the total
number of Nr5a1 expressing neurons in the VMH was unchanged (Fig. 16G-I; cSmo:
598.5 ± 100.7, n=8, versus control: 590.8 ± 196.4, n=6, p=0.9253). Moreover, fewer
Nr5a1 expressing neurons co-labeled with Nkx2.1 in cSmo embryos, which was
especially notable in ventral regions of the VMH where Gli1 is not normally expressed
(Fig. 16J-L). The presence of defects in regions of the tuberal hypothalamus that are not
known to be Shh responsive suggests that some of the phenotypes in cSmo embryos
may occur through non-cell autonomous mechanisms.
The seemingly incongruous findings that Nkx2.2 neurons are partially reduced in
the dorsal VMH of cSmo embryos without an effect on the total number of VMH cells
prompted us to reassess the specification of tuberal hypothalamic progenitors. Nkx2.1
marks a broad ventral region of the ventricular zone in control embryos at E14.5, from
the ventral midline of the hypothalamus to a dorsal limit that approximates the border
between the VMH and DMH (Fig. 17A). The expression of Nkx2.2 overlaps with Nkx2.1
at the level of the dorsal VMH and extends dorsally into the ventricular zone of the
prethalamus (Fig. 17A). There was a significant reduction in the number of cells
expressing Nkx2.1 in the ventricular zone of cSmo embryos (Fig. 17A; cSmo: 131.0 ±
80.4, n=5, versus control: 259.4 ± 58.9, n=5, p=0.0205) and a concomitant ventral
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expansion of Nkx2.2 (Fig. 17A; cSmo: 118.2 ± 42.9, n=9, versus control: 58.0 ± 23.2,
n=9, p=0.002). Given that Nkx2.2 is a direct transcriptional target of Shh signaling, it was
puzzling that its expression was increased in cSmo mutants (Lei et al., 2006; Vokes et
al., 2007). We evaluated other molecular readouts of Shh signaling and observed a
similar ventral expansion of Olig2 (cSmo: 125.8 ± 12.9, n=5, versus control: 73.4 ± 6.5,
n=5, p<0.0001) and Ki67 (cSmo: 107.0 ± 13.5, n=8, versus control: 81.8 ± 16.4, n=9,
p=0.0037) in cSmo embryos (Fig. 17B,C). Notably, the cells displaying ectopic
expression of Nkx2.2, Olig2 and Ki67 were not GFP positive, suggesting that they were
wild type cells that had not undergone Smo recombination (Fig. 18). No change in the
expression of Gli1 was observed between cSmo and control embryos at E14.5,
suggesting that the ectopic response to Shh signaling was transient and/or occurred at
an earlier stage (Fig. 17D). The most parsimonious explanation for these results is that
the conditional deletion of Smo prevented the normal uptake of Shh ligand, causing a
non-cell autonomous gain in Shh signaling in neighboring wild type cells (Fig. 17E).
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Discussion
Previous studies identified requirements for Shh at distinct spatial and temporal
points in hypothalamic development, from induction to nucleogenesis (Chiang et al.,
1996; Szabó et al., 2009; Shimogori et al., 2010; Zhao et al., 2012). Here, we further
define the phenotypic consequences and pathogenic mechanisms attributed to the loss
of Shh signaling at early (E9.0) and late (after E10.5) stages of hypothalamic
development. We determine that the loss of hypothalamic nuclei in cases where Shh
was deleted at early time points results from requirements for Shh in establishing proper
dorsoventral patterning, neurogenesis, and limiting the expansion of the non-proliferative
ventral midline. Using an inducible approach, we then characterize requirements for later
Shh activity, at time points after dorsoventral patterning has been established. We find
that Shh is necessary to maintain proliferation and subtype identity of VMH and DMH
progenitors during peak periods of hypothalamic neurogenesis.
Shh directs dorsoventral patterning and neurogenesis in the hypothalamus
Our results confirm that the early source of Shh in the hypothalamus is required
to generate the full complement of tuberal hypothalamic neurons (Szabó et al., 2009;
Shimogori et al., 2010; Zhao et al., 2012). In order to understand the mechanism
underlying the loss of these cell types in ShhΔhyp mutants, we evaluated embryos at
E10.5 and observed a failure to activate the appropriate patterning, proliferation and
neurogenic programs. This result is consistent with the known morphogenetic role of
Shh in establishing ventral neuronal identities through the regulation of homeodomain
and bHLH transcription factors with some notable differences described below (Ericson
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et al., 1997; Briscoe et al., 1999; Briscoe et al., 2000; Muhr et al., 2001; Balaskas et al.,
2012).
At spinal cord and hindbrain levels of the CNS, the notochord is the principle
source of Shh required to specify ventral neuronal progenitors, whereas, the secondary
source of Shh in the floor plate is needed for the formation of later born glial and
ependymal cells types (Matise et al., 1998; Yu et al., 2013). In contrast to the notochord,
the expression of Shh in the prechordal plate is transient and only present for sufficient
time to specify the hypothalamic territory, marked by Nkx2.1, but not the identity of
neuronal progenitors (Szabó et al., 2009). Instead, it is the hypothalamic source of Shh
that establishes VMH and DMH progenitor domains. Thus, whereas notochord derived
Shh activates target genes, such as Nkx2.2 and Olig2, in the overlying neural tube, a
similar function is fulfilled by the hypothalamic source of Shh. Given that hypothalamic
neurons develop over a protracted period compared to most spinal cord neurons, it
makes sense that they rely on an enduring source of Shh within the hypothalamus for
their development (Davis et al., 2004; Altman and Bayer, 2006; Ishii and Bouret, 2012).
Shh restricts ventral midline development in the tuberal hypothalamus
In addition to the dorsoventral patterning and neurogenic defects, our analysis of
Shh∆hyp mutants revealed an unexpected expansion of ventral midline identity. It is likely
that the increased number of ventral midline cells in Shh∆hyp embryos is a consequence
of heightened Bmp signaling as evidenced by the expanded zone of non-proliferation
and Tbx3 expression, two molecular readouts of this pathway (Manning et al., 2006).
Indeed, the loss of Shh signaling in the anterior hypothalamus of Shh∆hyp embryos was
previously shown to cause a rostral shift in Bmp4 expression as early as E9.5 (Zhao, et
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al., 2012). Interestingly, a similar phenotype was also observed in Lrp2-/- mutant
embryos, including a downregulation in Shh signaling, flattened and expanded ventral
midline, and a rostral shift in Bmp4 expression (Christ et al., 2012). Lrp2 belongs to the
LDL receptor gene family and binds both Shh (as a co-receptor) and Bmp4 (as a
scavenger receptor) (McCarthy et al., 2002; Spoelgen et al., 2005; Christ et al., 2012).
Therefore, a disruption in the balance of Shh and Bmp signaling, loss and gain
respectively, is responsible for the ventral midline defects in Lrp2-/- and ShhΔhyp mutants.
A role for Shh in restricting ventral midline development in the tuberal
hypothalamus is intriguing given the opposite function it plays in promoting floor plate
induction in posterior regions of the CNS (Echelard et al., 1993; Roelink et al., 1995;
Martí et al., 1995; Ericson et al., 1996; Chiang et al., 1996). Why might Shh have
contrasting roles in the development of ventral midline cells at different levels of the
neural tube? Firstly, the cells at the ventral midline of the tuberal hypothalamus, known
as the median eminence, differ from floor plate cells in the spinal cord in that they are
comprised of tanycytes, a specialized form of radial glia with neurogenic and gliogenic
properties (Rizzoti and Lovell-Badge, 2017). In mammals, floor plate cells of the spinal
cord are considered glial-like but do not give rise to neurons or glia. Tanycytes are an
integral component of the hypophyseal portal system that connects the hypothalamus to
the pituitary gland and regulate a variety of homeostatic processes given their access to
blood borne signals (Rodríguez et al., 2005; Robins et al., 2013; Bolborea and Dale,
2013). Secondly, the hypothalamic ventral midline is a site of integration for multiple
signaling pathways, including Shh, Bmp, Wnt and Fgf that help facilitate the unique
organization of the hypothalamic-pituitary axis (Manning et al., 2006; Davis and
Camper., 2007; Zhu et al., 2007; Potok et al., 2008; Zhao et al., 2012; Carreno et al.,
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2017; Fu et al., 2017). At the level of the spinal cord, Shh is the primary regulator of
ventral neuronal identities, with additional signals serving to modulate Shh
responsiveness (Gouti et al., 2015; Kong et al., 2015). Thirdly, Shh expressing cells in
the hypothalamus are different from elsewhere in the neural tube in that they constitute
actively dividing neuronal progenitors (Szabó et al., 2009; this study). Within the spinal
cord, Shh expressing floor plate cells lack neurogenic properties. Given the clear
differences in ventral development between the hypothalamus and spinal cord, it is not
altogether surprising that Shh exhibits unique and overlapping functions at each of these
CNS regions.
Later Shh signaling- delineating fates
We sought to investigate roles and requirements for the enduring source of Shh
in the tuberal hypothalamus. Our lineage tracing experiments revealed biased
contributions of Shh expressing and Shh responding lineages to the VMH and DMH. On
the basis of this observation, we wondered whether integration of progenitors may serve
as a potential means by which neuronal heterogeneity is achieved within these
hypothalamic nuclei.
Shh expressing and Shh responsive populations mix to give rise to the large
domain of Nr5a1 cells in the VMH, though their contributions remain somewhat spatially
discrete. Initially found broadly in the VMH, Nr5a1 expression becomes restricted to the
VMHDM by P0 (Cheung et al., 2013; Correa et al., 2015). Transcriptome analysis of the
VMH in both neonatal and adult mice has revealed enrichment of 200 genes relative to
expression in neighboring nuclei (Segal et al., 2005; Kurrasch et al., 2007). Examining
the patterns of these markers revealed distinct spatial domains and biases, some
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overlapping with Nr5a1 and some mutually exclusive. Thus, it is clear that VMH neurons
are diverse in nature. Molecular characterization of VMH neuronal subclasses has
largely been performed in postnatal animals. Specifically, Islet1 and ERα are restricted
to the VMHVL (Davis et al., 2004), BDNF to the VMHDM and VMHC (McClellan et al.,
2006), and leptin receptor to the VMHDM (Balthasar et al., 2004; Dhillon et al., 2006).
However, little is known regarding the processes through which these diverse
populations are specified. Thus, within the VMH, the ventral bias of cells derived from
Shh expressing progenitors and the dorsal bias of Gli1 expressing descendants may be
indicative of a role for Shh signaling as a means of delineating distinct fates within a
single nucleus.
The migration of a small number of Shh responsive progenitors into the VMH
bears similarity to other hypothalamic cell types that originate from outside of their local
progenitor territory. Most neuronal populations in the ARC are generated from
multipotent progenitors that migrate radially from the adjacent ventricular zone (Li et al.,
1996; McNay et al., 2006; Yee et al., 2009; Pelling et al., 2011; Lu et al., 2013; Lee et
al., 2016), however some cells migrate tangentially from distal locations. For instance,
GnRH neurons originate in the olfactory bulb and cross substantial distance to arrive at
their final location within the ARC (Wray et al., 1989; Wray, 2002). Moreover, gene
expression studies suggest that some Sst neurons migrate to the ARC from an anterior
hypothalamic birthplace (Morales-Delgado et al., 2011). We propose that the migration
of a Shh responsive cell population into the VMH, albeit from a nearby location, may
further explain how cellular diversity is achieved in this nucleus.
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Later Shh signaling- maintaining proliferation of progenitor pools
In assessing the requirements of Shh at later stages of hypothalamic
development, we observed a dependency on Shh for maintaining tuberal hypothalamic
progenitors in a mitotically active state. When Shh signaling was disrupted after E10.5,
there were fewer cSmo mutant cells in the VMH and DMH due to reduced cell division.
Thus, Shh signaling is required to maintain hypothalamic progenitors in a mitotically
active state during peak periods of VMH and DMH neurogenesis. These results are
consistent with previous findings demonstrating a mitogenic role for Shh in other
neurodevelopmental contexts (Rowitch et al.,1999; Wallace, 1999; Wechsler-Reya and
Scott, 1999; Fuccillo et al., 2006; Komada et al., 2008).
Non-cell autonomous phenotypes in cSmo mutants due to heightened Shh
signaling
Our analysis of cSmo embryos also revealed that Shh is required to maintain the
subtype identity of postmitotic VMH neurons. Despite the reduced number of Nkx2.2 +,
GFP+ neurons in the dorsal VMH of cSmo embryos, the total number of VMH neurons
was unchanged. Moreover, fewer VMH neurons expressed Nkx2.1, especially in ventral
regions where Smo was not deleted. We propose a non-cell autonomous mechanism to
account for some of these differences in VMH neuron identity, whereby residual Shh
ligand that was not taken up by cSmo mutant cells signaled to adjacent wild type
progenitors, altering their patterns of gene expression and proliferation. In further
support of this claim, a similar non-cell autonomous upregulation of Shh signaling was
previously described upon the mosaic deletion of Smo in the ventral telencephalon (Xu
et al., 2010).
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Our observation of increased Shh signaling in non-recombined cells from cSmo
mutant embryos is provocative in light of the association of somatic mutations in
regulators of Shh signaling with hypothalamic hamartomas (Craig et al., 2008; Wallace
et al., 2008; Hildebrand et al., 2016; Saitsu et al., 2016). Hypothalamic hamartomas are
benign tumors that form during fetal brain development and, depending on their size and
location, may disrupt endocrine function and cause seizures. Dominant mutations in
GLI3 that produce a truncated protein with constitutive repressor activity were identified
in hypothalamic hamartomas (Craig et al., 2008; Wallace et al., 2008; Hildebrand et al.,
2016; Saitsu et al., 2016). Individuals with Pallister Hall syndrome possess similar
germline truncating mutations in GLI3 and also develop hypothalamic hamartomas
(Kang et al., 1997). Mutations in other components of the SHH signaling pathway, OFD1
and PRKRAC (encoding the catalytic subunit ɑ of PKA), have also been described in
resected hamartoma tissue (Hildebrand et al., 2016; Saitsu et al., 2016).
The mechanism of hypothalamic hamartoma formation is unknown.
Paradoxically, the mutations that have been described in SHH pathway components are
generally thought to inhibit SHH signaling, which, given its mitogenic activity, would be
expected to suppress rather than promote the growth of this ectopic mass. Interestingly,
the allele rate for somatic mutations in GLI3 and OFD1 ranged from 7-54%, suggesting
that in some instances only a fraction of the cells in a given hypothalamic hamartoma
may actually contain mutations (Saitsu et al., 2016). As with the cSmo mutants
described in our study, somatic mosaicism in hypothalamic hamartomas may provide
wild type cells with a temporary boost in SHH signaling and transient growth advantage,
due to reduced ligand uptake by mutant cells that have lost their responsiveness to
SHH. While experiments in our study did not extend into postnatal life and may not have
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targeted enough cells to induce hypothalamic hamartomas, they do nevertheless offer a
compelling explanation for how these ectopic growths might form during brain
development.
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Materials and Methods
Mice
All animal work was approved by the Institutional Animal Care and Use Committee
(IACUC) at the Perelman School of Medicine, University of Pennsylvania. The SBE2-cre
mouse line was previously described (Zhao, et al., 2012). Gli1CreER (Gli1tm3(cre/ERT2)Alj),
Gli1lacZ (Gli1 tm2Alj), RosaZsGreen (Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze), Shh+/−, Shhloxp/loxp
(Shhtm2Amc), ShhCreER (Shh tm2(cre/ERT2)Cjt), Smo+/- (Smotm1Amc), and Smoloxp/loxp (Smotm2Amc)
mouse strains were procured from the Jackson labs (Bar Harbor, ME). Tamoxifen
dissolved in corn oil was orally gavaged at 0.15 mg/g body weight to pregnant dams at
appropriate developmental time points.

Tissue dissection
Embryos were collected at the stated developmental age, with noon of plug day
designated E0.5. Heads were dissected in cold PBS and fixed in 4% paraformaldehyde
(PFA) for 90 minutes to overnight at 4°C. Heads were then cryoprotected in 30%
sucrose and embedded in Tissue-Tek OCT Compound. Frozen tissue was
cryosectioned at 16 µm (for E12.5 and E13.5 embryos), 18 µm (for E14.5 embryos), or
20 µm (for E10.5 and E18.5 embryos).

Immunohistochemistry and section in situ hybridization
Immunohistochemistry was performed with the following antibodies: mouse anti-Ascl1
(1:100 BD Pharmingen, 556604), mouse anti-Gad1 (1:500, EMD Millipore, MAB5406),
mouse anti-Isl1 (1:100, Developmental Studies Hybridoma Bank, 39.4D5), rabbit anti66

Ki67 (1:1000, Novocastra. NCL-Ki67p), rabbit anti-Nkx2.1 (1:1000, Abcam, AB76013),
mouse anti-Nkx2.2 (1:1000, DSHB, 74.5A5), rabbit anti-Olig2 (1:500, Millipore, AB9610),
mouse anti-Pax6 (1:1000, Developmental Studies Hybridoma Bank, Pax6), rabbit antiPOMC (1:500, Phoenix Pharmaceuticals Inc., H-029-30), mouse anti- Nr5a1 (1:200,
R&D Systems, PP-N1665), rat anti-Somatostatin (1:200, Millipore, MAB354) rabbit antiTyrosine Hydroxlase (1:1000, Pel-Freez, P40101-0). Somatostatin, Pax6, Nkx2.2,
Nr5a1, Gad1, and Isl1 antibodies required antigen retrieval in 10mM citric acid buffer pH
6.0 at 90° C. Mouse on Mouse detection kit (Vector Laboratories BMK-2202) was used
for blocking and primary antibody dilution of Nkx2.2, Gad1, and Isl1 antibodies.
Detection of primary antibodies was achieved using secondary antibodies conjugated to
Cy3 anti-rabbit (1:200, 111-165-003, Jackson ImmunoResearch Laboratories), Cy3 antimouse (1:200, 115-166-006, Jackson ImmunoResearch Laboratories), Cy3 anti-rat
(1:200, 112-166-003, Jackson ImmunoResearch Laboratories) or AlexaFluor 633 antirabbit (1:100, Invitrogen, A21070).
Section in situ hybridization with digoxygenin-UTP-labeled riboprobes was
performed as described (Nissim et al., 2007). A minimum of three each of control and
mutant embryos were evaluated for each antibody or in situ probe.

β-galactosidase staining
Heads from Gli1lacZ/+ embryos were dissected in cold PBS and fixed in 4%
paraformaldehyde (PFA) for 90 minutes at 4°C. Heads were then cryoprotected in 30%
sucrose and embedded in Tissue-Tek OCT Compound. Frozen tissue was
cryosectioned at 20 µm. Slides were then stained in a solution containing 1 mg/ml X-gal

67

at 37°C overnight. Following staining, slides were post-fixed in 4% PFA and washed in
PBS.

Quantification and statistical analysis
All cell counts were performed using the cell counter function in ImageJ (NIH) on tissue
sections from at least three control and mutant embryos. In cases where double labeling
was examined for GFP and another cell specific marker, the tissue was imaged at a
single Z-plane. Each channel (green for GFP, red for the marker) was first examined
independently, assigning a positive count for a given marker to the DAPI stained nucleus
most closely associated with the staining. A cell was only counted as double labeled if a
single nucleus marked by DAPI had been assigned to the cell labeled by GFP and the
cell specific marker. Statistical analysis of all cell counts was performed in GraphPad
Prism using the Student’s t-test.
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Chapter 3 Figures

Figure 9. Loss of tuberal hypothalamic neurons in ShhΔhyp embryos.
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Coronal sections through the tuberal hypothalamus of control and ShhΔhyp embryos
stained by RNA in situ hybridization (A-D) or immunofluorescence (E-J) at E14.5 for
neuronal markers. (A,B) Hmx3 is expressed in the DMH of control embryos, and shows
reduced (bracket) and ectopic (asterisk) expression in ShhΔhyp mutants (n=3). (C,D)
Nr5a1 marks the VMH in control embryos and is absent in ShhΔhyp mutants (n=4). (E-K)
Markers of distinct neuronal subtypes in the ARC (POMC, TH, and Sst) are reduced or
absent in ShhΔhyp mutants (n=5 for POMC, **p=0.0004; n=4 for TH, ***p<0.0001; n= 3 for
Sst, ***p<0.0001). (L,M) Schematic of coronal sections through the tuberal
hypothalamus of control and ShhΔhyp embryos showing nuclei and cell type specific
markers. (N) Sagittal view of brain showing plane of section (red line) in (L-M). Scale
bars: 100 µm. Error bars indicate S.D. Statistical analysis was performed using a twotailed unpaired t-test.
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Figure 10. Altered dorsoventral patterning, neurogenesis, and ventral midline
development in ShhΔhyp embryos.
Coronal sections through control and ShhΔhyp embryos stained by RNA in situ
hybridization (A,B,G-I,N) or immunofluorescence (C-F,J-M) at E10.5. (A,H) Shh
expression in the prospective tuberal hypothalamus is lost in ShhΔhyp mutants (n=3). (B,I)
Gli1 expression in neuronal progenitors immediately dorsal to Shh is absent in ShhΔhyp
mutants (n=3). (C,J,O) Ventral hypothalamic expression of Nkx2.1 is reduced in ShhΔhyp
mutants (n=5 for controls, n=6 for ShhΔhyp), whereas Pax6 is expanded ventrally. Note
the gap between Nkx2.1 and Pax6 (white bracket) in control embryos is missing in
ShhΔhyp mutants. (D,K,P) Nkx2.2 expression in Shh responsive tuberal hypothalamic
progenitors is greatly reduced in ShhΔhyp mutants (n=4 for controls, n=5 for ShhΔhyp).
(E,L,Q) Ascl1 expression in neurogenic progenitors is reduced in ShhΔhyp mutants (n=3).
(F,M,R) The number of non-proliferating ventral midline cells identified by the absence of
Ki67 staining is expanded in ShhΔhyp mutants (n=4). (G,N,S) The expression of Tbx3 in
the ventral midline is expanded in ShhΔhyp mutants (n=3). Scale bars: 100 µm. Error
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bars indicate S.D. Statistical analysis was performed using a two-tailed unpaired t-test
(**p<0.0001).
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Figure 11. Persistence of Shh signaling during peak periods of hypothalamic
neurogenesis.
Coronal sections through the hypothalamus of (A) wild type and (B) Gli1lacZ/+ embryos at
E12.5. (A) RNA in situ hybridization detects Shh expression along the rostrocaudal axis
of the hypothalamus. Weak Shh expression is detected in the ventral midline at preoptic
and anterior hypothalamic regions. Shh expression is maintained in hypothalamic
progenitors adjacent to the ventral midline in tuberal and mammillary regions. Shh is
also observed in the zona limitans intrathalamica (red arrowhead) in the caudal
diencephalon. (B) X-gal staining of Gli1lacZ embryos along the rostrocaudal axis of the
hypothalamus. X-gal staining is detected adjacent to Shh expressing domains
throughout the hypothalamus. At the level of the tuberal hypothalamus, X-gal staining
marks progenitors of the DMH and a population of cells that stream ventrally towards the
VMH (arrows). Scale bars: 200 µm.
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Figure 12. Shh and Gli1 expressing cells contribute to overlapping and distinct
tuberal hypothalamic nuclei.
Coronal sections through the tuberal hypothalamus of ShhCreER/+; RosaZsGreen/+ (A-C,H, I)
and Gli1CreER/+; RosaZsGreen/+ (D-F,K,L) embryos at E14.5 that received tamoxifen at
E10.5. The fate of Shh and Gli1 expressing cells was determined by co-labeling with
GFP (ZsGreen) and cell type specific markers of the VMH and DMH. Insets in (A-F) are
higher magnification views of boxed regions showing single and double labeled cells.
(G,N) Quantification of fate-mapping experiments displayed as the proportion of double
positive cells (from either Shh or Gli1 lineages) to the total number of cells expressing a
given marker: Nr5a1(***p<0.0001, n=3); Nkx2.2 (*p=0.038, n=4 for Shh lineage, n=3 for
Gli1 lineage); Nkx2.1 (***p<0.0001, n=3); Isl1 (**p<0.0003, n=3). (J,M) Schematic
demonstrating contribution of Shh and Gli1 expressing cell lineages to tuberal
hypopthalamic nuclei. Scale bars: 100 µm. Inset scale bars: 25 µm. Error bars indicate
74

S.D. Statistical analysis was performed using a two-tailed unpaired t-test on arcsintransformed data.
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Figure 13. Shh and Gli1 lineages occupy distinct regions of the VMH.
Coronal sections through the tuberal hypothalamus of (A) ShhCreER/+; RosaZsGreen/+ and
(B) Gli1CreER/+; RosaZsGreen/+ embryos at E18.5 that received tamoxifen at E10.5. GFP
(ZsGreen) fluorescence is shown on sections counterstained with DAPI. (A) Cells that
expressed Shh at E10.5, contribute to the ventral and central regions of the VMH at
E18.5. (B) Cells that expressed Gli1 at E10.5, contribute to the DMH and dorsal region
of the VMH at E18.5. Scale bar: 100 µm. White dashed lines outline tuberal
hypothalamic nuclei.
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Figure 14. Shh signaling is required for proliferation of tuberal hypothalamic
progenitors.
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Coronal sections through the tuberal hypothalamus of control and cSmo embryos at
E14.5 (A,B), E13.5 (D,E), and E12.5 (G,H,J,K) that received tamoxifen at E10.5. (A-H)
GFP (ZsGreen) fluorescence is shown on sections counterstained with DAPI. (C,F,I)
Quantification of GFP positive cells from cSmo and control embryos tracked by litter. (JK) Co-labeling of GFP and Ki67 expressing cells (arrowhead) in the ventricular zone
reveals less proliferation in cSmo embryos at E12.5, as quantified in (L). Scale bars: (AH) 100 µm (J-K) 25 µm. For all graphs, horizontal dotted line represents the mean and
error bars indicate S.D. Each data point represents a single embryo that is color-coded
by litter. Statistical analysis was performed using a two-tailed unpaired t-test
(***p=0.0003, **p=0.0066, *p=0.0249).
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Figure 15. No differences in cell death between control and cSmo embryos.
Coronal sections of control and cSmo embryos at E14.5 that received tamoxifen at
E10.5. Immunostaining for activated caspase-3 counterstained with DAPI reveals no
differences in apoptosis between control and cSmo embryos (control n=5, 4.4 ± 1.3;
cSmo n=4, 3.5 ± 1.3; p>0.05). Each data point represents a single embryo color-coded
by litter. Scale bars:100 µm. Statistical analysis was performed using a two-tailed
unpaired t-test.
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Figure 16. Shh signaling is required for subtype identity of VMH and DMH
neurons.
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Coronal sections through the tuberal hypothalamus of control and cSmo embryos at
E14.5 that received tamoxifen at E10.5. (A-C) The number of cells expressing Isl1 in the
DMH is reduced in cSmo embryos (control n=4, cSmo n= 5, *p=0.0229). (D-F) The
number of post mitotic neurons expressing Nkx2.2 in the dorsal VMH is reduced in cSmo
embryos compared to control littermates (n=9, **p<0.0001). (G-I) The number of VMH
neurons expressing Nr5a1 is equivalent between control and cSmo embryos (control
n=6, cSmo n= 8, ns p>0.05). (J-L) The number of post-mitotic neurons expressing
Nkx2.1 in the tuberal hypothalamus is reduced in cSmo embryos (n=5, *p=0.0174). For
all graphs, horizontal dotted line represents the mean and error bars indicate S.D. Each
data point represents a single embryo that is color-coded by litter. Statistical analysis
was performed using a two-tailed unpaired t-test.
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Figure 17. Non-cell autonomous alterations in hypothalamic progenitors in cSmo
embryos.
Coronal sections through the tuberal hypothalamus of control and cSmo embryos at
E14.5 (tamoxifen administered at E10.5). (A) The boundary between Nkx2.1 and Nk2.2
expressing progenitors (yellow bracket) is shifted ventrally in the ventricular zone of
cSmo embryos compared to control littermates. The ventral expansion of Nkx2.2
expressing progenitors (n=9, **p=0.002) is concomitant with a reduction in the number of
cells expressing Nkx2.1 (n=5, *p=0.0205). (B) Olig2 is ectopically expressed in ventral
tuberal hypothalamic progenitors in cSmo embryos compared to control littermates (n=5,
***p<0.0001). (C) Ki67 is ectopically expressed in ventral tuberal hypothalamic
progenitors in cSmo embryos compared to control littermates (control n=9, cSmo n=8,
**p=0.0037). (D) Gli1 expression is unchanged between control and cSmo embryos
(n=3). (E) Schematic model depicting the non-cell autonomous gain in Shh
82

responsiveness by ventral tuberal hypothalamic progenitors in cSmo mutant embryos
compared to control littermates. For all graphs, horizontal dotted line represents the
mean and error bars indicate S.D. Each data point represents a single embryo that is
color-coded by litter. Statistical analysis was performed using a two-tailed unpaired ttest. Scale bars: 50 µm.
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Figure 18. cSmo embryos show ectopic activation of Shh responsive genes in
non-recombined (wild type) cells.
Coronal sections through the tuberal hypothalamus of control and cSmo embryos at
E14.5 (tamoxifen administered at E10.5). Shh responsive progenitors in control embryos
frequently co-label with GFP and Nkx2.2, Olig2, or Ki67 (open arrowhead). The majority
of progenitors in cSmo embryos showing ectopic expression of Nkx2.2, Olig2, or Ki67 do
not co-label with GFP (closed arrowheads), suggesting that they derive from nonrecombined (wild type) cells. (A,B) The ventral boundary of Nkx2.2 and Olig2 expression
(white dotted bracket) is shifted ventrally in cSmo embryos. The same images are shown
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in Figure 6 without the GFP overlay. For all graphs, horizontal dotted line represents the
mean and error bars indicate S.D. Each data point represents a single embryo that is
color-coded by litter. Statistical analysis was performed using a two-tailed unpaired t-test
(**p=0.0003, ***p<0.0001). Scale bar: 50 µm.
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CHAPTER 4: Conclusions and Future Directions
One of the foremost questions in the field of developmental biology is how the
limited molecular toolkit encoded in the genome is used iteratively to give rise to
complex structures composed of heterogenous cell types. The hypothalamus has been
extensively studied for that very reason. Though it is derived from the neural tube in the
same manner as other structures of the central nervous system, the hypothalamus
requires precise temporal regulation of Shh expression and signaling domains for proper
development.

Distinct roles for Shh in the hypothalamus:
Previous studies have identified requirements for Shh at distinct spatial and
temporal points in hypothalamic development, from early induction to nucleogenesis
(Chiang et al., 1996; Szabó et al., 2009; Shimogori et al., 2010; Zhao et al., 2012). In
addition to providing an atlas of hypothalamic gene expression, Shimogori and
colleagues also hinted at requirements for the hypothalamic source of Shh. Using an
Nkx2.1-Cre line to delete Shh, they found a profound disruption of hypothalamic nuclei
and loss of gene expression along the rostrocaudal axis (Shimogori et al., 2010).
However, this work was descriptive in nature and any mechanism underlying the loss of
hypothalamic populations was not suggested. Further studies of roles for Shh and its
corresponding signaling activity in the hypothalamus soon followed. In 2012, AlvarezBolado and colleagues further described the dynamic pattern of Shh expression in the
developing hypothalamus (Alvarez-Bolado, et al., 2012). Using genetic inducible fate
mapping techniques driven by the ShhCreER mouse line, they uncovered the contribution
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of Shh expressing cells and their progeny to the hypothalamic territories. They found
cells expressing Shh before E9.5 give rise to neurons and astrocytes populating the
preoptic, tuberal, and mammillary hypothalamus. Later induction time points, in contrast,
resulted in progressively smaller contributions to the preoptic and mammillary
hypothalamus. The tuberal hypothalamus saw a steady contribution of Shh-expressing
cells at the level of the VMH during the remainder of neurogenesis (Alvarez-Bolado, et
al., 2012). Previous work from our lab described a requirement for early Shh in
establishing proper patterning of the hypothalamus along the anteroposterior axis and
for proper placement and specification of the pituitary (Zhao, et al., 2012).
The work presented in the preceding chapters serves to further characterize the
phenotypic consequences and pathogenic mechanisms attributed to the loss of Shh
signaling at early (E9.0) and late (after E10.5) stages of hypothalamic development. We
determine that the loss of hypothalamic nuclei in cases where Shh is deleted at early
time points results from additional requirements for Shh in establishing proper
dorsoventral patterning, neurogenesis, and limiting the expansion of the non-proliferative
ventral midline. Using an inducible and conditional approach, we then characterize
requirements for later Shh activity, at time points after dorsoventral patterning has been
established. We find that Shh is necessary to maintain proliferation and subtype identity
of VMH and DMH progenitors during peak periods of hypothalamic neurogenesis. Later,
Shh acts as a mitogen to ensure proper proliferation and expansion of progenitors to
give rise to the full complement of tuberal hypothalamic neurons.
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Shh-expressing cells in the hypothalmus are unique:
Our analysis of Shh∆hyp mutants revealed an unexpected phenotype within the
ventral midline of the hypothalamus. In Shh∆hyp mutants, we observed an expansion of
midline identity. This potential role for Shh in restricting ventral midline development in
the tuberal hypothalamus is intriguing given the function associated with Shh in more
posterior regions of the CNS where Shh promotes floor plate identity in the (Echelard et
al., 1993; Roelink et al., 1995; Martí et al., 1995; Ericson et al., 1996; Chiang et al.,
1996). We hypothesized that this distinct role of Shh in limiting the ventral midline may
be in part due to the different nature of midline cells at this level. At more posterior levels
of the central nervous system in mammals, floor plate cells of the spinal cord are
considered glial-like but do not give rise to neurons or glia. However, the specialized
tanycyte glial cells in the hypothalamic midline connects the hypothalamus to the
pituitary gland and regulate a variety of homeostatic processes given their access to
blood borne signals (Rodríguez et al., 2005; Robins et al., 2013; Bolborea and Dale,
2013). Additionally, the fact that the hypothalamic ventral midline is a site of integration
for multiple signaling pathways, including Shh, Bmp, Wnt and Fgf may explain a different
role for Shh in the midline cells at this level (Gouti et al., 2015; Kong et al., 2015).
Perhaps the most striking difference of the hypothalamus is that the Shh
expressing cells in the hypothalamus are different from elsewhere in the neural tube in
that they constitute actively dividing neuronal progenitors (Szabó et al., 2009). Within the
spinal cord, Shh expressing floor plate cells lack neurogenic properties. Further
highlighting this unique feature of neurogenic progenitors expressing Shh is that in the
neurogenic midline of the midbrain, progenitors must extinguish Shh expression (Bayly
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et al., 2007; Joksimovic et al., 2009; Joksimovic et al., 2009b; Perez-Balaguer et al.,
2009).
Heterogeneity of hypothalamic neurons:
The developmental mechanisms regulating the vast neuronal heterogeneity
within the hypothalamus remains poorly understood compared to other regions of the
central nervous system (Bedont et al., 2015; Burbridge et al., 2016; Xie and Dorsky,
2017). In fact, the extent of that heterogeneity is still being realized. In a seminal paper,
Shimogori and colleagues used high throughput techniques to catalog gene expression
of the developing hypothalamus (Shimogori, et al., 2010). Hypothalamic tissue was
collected from brains at each day of development beginning in mid-gestation (E10.5) as
well as early postnatal and adult stages. Microarray experiments on this panel of tissue
highlighted subsets of genes expressed during development as well as those that
became markers of mature neuron populations. Further, these authors went on to
perform large-scale in situ hybridization analysis to describe the general and/or regionspecific expression patterns of transcription factors and neuropeptides at different time
points of hypothalamic development. The advent of single-cell techniques including
Drop-Seq have also proved useful in further characterizing the diversity of cell types in
the tuberal hypothalamus (Campbell et al., 2017).
The work presented in Chapter 3 of this work serves to uncover some of the
factors that may act along the differentiation pathways of subpopulations within the
VMH. Of note we find the dorsomedial VMH population of neurons which are marked by
post-mitotitc expression of Nkx2.2 are likely derived from a Shh-responsive population.
Gene expression analysis of adult hypothalamic issue suggests these dorsomedial VMH
89

neurons include a leptin receptor expressing population implicated in mediating effects
on body weight (Dhillon et al., 2006; Kurrasch et al., 2007) However, this population of
Nkx2.2 expressing cells has been minimally described in the literature. Additional
experiments are necessary to identify requirements for Shh signaling within these
compartments as well as other factors that may further define them.
Furthermore, experiments beyond the scope of the work presented here could
address the lineage of adult neuronal populations in the tuberal hypothalamus. As fate
mapping experiments using the Gli1CreER and ShhCreER mouse lines were carried out as
late as E18.5, we have yet to track the fate of these lineages in the adult hypothalamus.
The expression of numerous markers of mature hypothalamic cell types and active
neurons are difficult to assess at embryonic time points. Thus, carrying these
experiments into early and later postnatal life would allow for the examination of a larger
set of gene expression markers.
Mosaic nature of Hh deletion:
The experiments presented in Chapter 3 made use of inducible and conditional
approaches to attenuate Hh signaling in mice. These approaches targeted the obligate
transducer of the Hh pathway, Smo in a Hh-signaling dependent manner. Thus, our
approach allowed for the disruption of further Hh signaling only in those cells which were
already Hh responsive. Ideally, additional experiments would be performed using
complementary approach in which the ligand of the pathway is deleted. However,
because we took this experimental approach, we were able to take advantage of the
mosaic nature of conditional Smo deletion. This allowed for the unique opportunity to
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observe both recombined and non-recombined cells within the context of a single
animal.
In fact, we observed hyperproliferation of non-recombined cells in a tamoxifentreated animal. Furthermore, we saw increased Nkx2.2 and Olig2 expression in the
ventricular zone of cSmo animals. This is of interest for two reasons. First, Nkx2.2 is a
direct transcriptional target of Shh signaling while Olig2 is known to be induced following
high levels of Shh signaling. Second, the cells which ectopically expressed Nkx2.2 and
Olig2 were largel, negative for our marker of recombination (ZsGreen). This is indicative
of wild type cells experiencing higher levels of Shh signaling in cSmo mutant embryos.
It is possible that the lack of ligand uptake by cSmo cells allows for inappropriate
spreading of ligand to cells that would normally not respond to Shh. This is not the first
example of a mosaic deletion of Smo resulting in ectopic activation of the Shh signaling
pathway in normally non-responsive cells. In one such example, neighbors of MGE cells
which have been made refractory to Shh signaling through Six3-Cre mediated deletion
of Smo exhibited surprising upregulation of Shh pathway targets and compensated for a
loss of mutant-derived somatostatin expressing neurons (Xu et al., 2010). An additional
explanation for the ectopic Hh signaling observed in cSmo animals is that targeted cells
may fail to properly express secreted inhibitors of the Shh signaling pathway. At present,
we can not rule out the possibility that cSmo cells may fail to express secreted inhibitors
that would normally limit signaling. In this
As stated in Chapter 3, the observed phenotype of our cSmo mice which may
display an increase of Shh signaling output in non-recombined cells was reminiscent of a
human condition in which patients harbor mutations in regulators of the Hedgehog
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pathway. In sporadic cases of Pallister Hall Syndrome with hypothalamic hamartomas
(HH), truncating mutations in or loss of heterozygosity at the genomic region surrounding
Gli3 are often seen as the causative genetic factors. Known mutations cluster near the
DNA-binding and transactivation domains of Gli3 to produce a truncated protein, which
acts as a constitutive repressor of Hh signaling (Craig et al., 2008; Démurger et al.,
2015; Saitsu et al., 2016). Mutations in additional negative regulators of the Hh signaling
pathway, OFD1 and PRKRAC (encoding the catalytic subunit ɑ of PKA), have also been
described in resected HH tissue (Hildebrand et al., 2016; Saitsu et al., 2016).
One of the prevailing models in the study of HH is that neighboring cells not
harboring the mutations are exposed to higher levels of Shh signaling due to a lack of
ligand uptake. While the experiments within the scope of our study did not extend into
postnatal life and may not have targeted enough cells sufficient to induce HH, the
similarity of non-cell autonomous phenotypes observed here in cases of mosaic
recombination of Smo and those present in HH is intriguing. Though HH can be
comprised of predominantly neurons or glia, our observation of ectopic Olig2 expression
in cSmo mutants may indicate bias towards giving rise to a glial HH (Coons et al., 2007).
Previous attempts to establish mouse models of HH have not been fruitful. Future study
using this particular genetic model may prove useful as a mouse model of HH.
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